[
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.5,
    "95% CI (%)": "4.7 - 8.4",
    "Sample Size": 2428,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.2,
    "95% CI (%)": "4.6 - 7.8",
    "Sample Size": 3310,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 2.4,
    "95% CI (%)": "1.2 - 3.7",
    "Sample Size": 1748,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.6,
    "95% CI (%)": "13.6 - 19.6",
    "Sample Size": 2838,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.5,
    "95% CI (%)": "13.3 - 21.6",
    "Sample Size": 1731,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 32.2,
    "95% CI (%)": "24.9 - 39.6",
    "Sample Size": 827,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 13.5,
    "95% CI (%)": "7.9 - 19.0",
    "Sample Size": 755,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.8,
    "95% CI (%)": "4.0 - 11.5",
    "Sample Size": 835,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 18.6,
    "95% CI (%)": "15.1 - 22.1",
    "Sample Size": 2405,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.5,
    "95% CI (%)": "6.3 - 10.7",
    "Sample Size": 2399,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Worse than other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.2,
    "95% CI (%)": "0.0 - 17.2",
    "Sample Size": 135,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 2.3,
    "95% CI (%)": "1.1 - 3.5",
    "Sample Size": 1746,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 15.1,
    "95% CI (%)": "9.6 - 20.6",
    "Sample Size": 794,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.8,
    "95% CI (%)": "13.2 - 22.4",
    "Sample Size": 1085,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.8,
    "95% CI (%)": "2.4 - 15.3",
    "Sample Size": 318,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.4,
    "95% CI (%)": "5.9 - 16.8",
    "Sample Size": 462,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.4,
    "95% CI (%)": "8.3 - 12.5",
    "Sample Size": 3457,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.4,
    "95% CI (%)": "9.4 - 15.3",
    "Sample Size": 2074,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.9,
    "95% CI (%)": "5.9 - 10.0",
    "Sample Size": 3043,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.6,
    "95% CI (%)": "4.4 - 18.7",
    "Sample Size": 348,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.4,
    "95% CI (%)": "8.3 - 12.5",
    "Sample Size": 3699,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.4,
    "95% CI (%)": "1.0 - 9.9",
    "Sample Size": 129,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 9.7,
    "95% CI (%)": "5.4 - 14.0",
    "Sample Size": 842,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Asian, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.1,
    "95% CI (%)": "3.6 - 28.5",
    "Sample Size": 207,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.2,
    "95% CI (%)": "5.1 - 11.4",
    "Sample Size": 1480,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.6,
    "95% CI (%)": "9.5 - 15.7",
    "Sample Size": 1766,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.4,
    "95% CI (%)": "4.3 - 12.4",
    "Sample Size": 448,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.2,
    "95% CI (%)": "2.6 - 13.8",
    "Sample Size": 444,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.4,
    "95% CI (%)": "6.0 - 10.9",
    "Sample Size": 2099,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.3,
    "95% CI (%)": "7.3 - 13.3",
    "Sample Size": 1681,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.5,
    "95% CI (%)": "9.3 - 13.7",
    "Sample Size": 3735,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12,
    "95% CI (%)": "8.3 - 15.7",
    "Sample Size": 1206,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.1,
    "95% CI (%)": "9.9 - 14.4",
    "Sample Size": 3519,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "Spanish",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 3.1,
    "95% CI (%)": "0.4 - 5.8",
    "Sample Size": 420,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Not insured",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 1.9,
    "95% CI (%)": "0.1 - 3.8",
    "Sample Size": 524,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.7,
    "95% CI (%)": "4.2 - 11.3",
    "Sample Size": 840,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.7,
    "95% CI (%)": "8.3 - 13.1",
    "Sample Size": 3339,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.3,
    "95% CI (%)": "9.0 - 13.6",
    "Sample Size": 3131,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 44.4,
    "95% CI (%)": "32.0 - 56.8",
    "Sample Size": 411,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 2.4,
    "95% CI (%)": "1.3 - 3.6",
    "Sample Size": 2960,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11,
    "95% CI (%)": "9.0 - 13.1",
    "Sample Size": 3994,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 38,
    "95% CI (%)": "31.6 - 44.4",
    "Sample Size": 1203,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.1,
    "95% CI (%)": "8.0 - 16.3",
    "Sample Size": 1109,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 13,
    "95% CI (%)": "6.3 - 19.7",
    "Sample Size": 293,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 0.6,
    "95% CI (%)": "0.0 - 1.2",
    "Sample Size": 112,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.6,
    "95% CI (%)": "0.0 - 12.1",
    "Sample Size": 258,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.7,
    "95% CI (%)": "2.8 - 10.6",
    "Sample Size": 838,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11,
    "95% CI (%)": "8.9 - 13.0",
    "Sample Size": 3887,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.3,
    "95% CI (%)": "9.2 - 13.3",
    "Sample Size": 3941,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.7,
    "95% CI (%)": "3.1 - 12.2",
    "Sample Size": 454,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.1,
    "95% CI (%)": "3.9 - 18.3",
    "Sample Size": 349,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 26.6,
    "95% CI (%)": "18.5 - 34.6",
    "Sample Size": 632,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.1,
    "95% CI (%)": "9.1 - 15.1",
    "Sample Size": 2452,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 22.1,
    "95% CI (%)": "16.5 - 27.6",
    "Sample Size": 1141,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 9.4,
    "95% CI (%)": "6.7 - 12.2",
    "Sample Size": 1561,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 2.9,
    "95% CI (%)": "0.0 - 7.0",
    "Sample Size": 142,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 2.2,
    "95% CI (%)": "0.0 - 4.5",
    "Sample Size": 164,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.1,
    "95% CI (%)": "4.8 - 9.5",
    "Sample Size": 1997,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.8,
    "95% CI (%)": "8.8 - 12.8",
    "Sample Size": 4018,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.9,
    "95% CI (%)": "8.9 - 12.9",
    "Sample Size": 3990,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.0 - 3.5",
    "Sample Size": 143,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.8,
    "95% CI (%)": "8.8 - 12.8",
    "Sample Size": 3973,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.9,
    "95% CI (%)": "8.9 - 12.9",
    "Sample Size": 4013,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.5,
    "95% CI (%)": "0.0 - 11.9",
    "Sample Size": 160,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.3,
    "95% CI (%)": "0.0 - 12.5",
    "Sample Size": 125,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is a little difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.5,
    "95% CI (%)": "0.0 - 13.0",
    "Sample Size": 283,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.4,
    "95% CI (%)": "4.3 - 12.4",
    "Sample Size": 448,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is somewhat difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.8,
    "95% CI (%)": "1.1 - 22.4",
    "Sample Size": 127,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.6,
    "95% CI (%)": "9.5 - 15.7",
    "Sample Size": 1766,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.4,
    "95% CI (%)": "9.2 - 13.6",
    "Sample Size": 3623,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.8,
    "95% CI (%)": "3.8 - 17.9",
    "Sample Size": 369,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 19.2,
    "95% CI (%)": "15.6 - 22.9",
    "Sample Size": 2283,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 0.7,
    "95% CI (%)": "0.2 - 1.3",
    "Sample Size": 1287,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.2,
    "95% CI (%)": "5.1 - 11.4",
    "Sample Size": 1480,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is very difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 0.3,
    "95% CI (%)": "0.0 - 0.8",
    "Sample Size": 100,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 15.9,
    "95% CI (%)": "0.0 - 36.9",
    "Sample Size": 31,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 0.5,
    "95% CI (%)": "0.0 - 1.3",
    "Sample Size": 31,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.3,
    "95% CI (%)": "6.6 - 14.0",
    "Sample Size": 1035,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.4,
    "95% CI (%)": "8.5 - 12.4",
    "Sample Size": 4173,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 9.7,
    "95% CI (%)": "5.2 - 14.1",
    "Sample Size": 453,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Low SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 13.5,
    "95% CI (%)": "6.2 - 20.7",
    "Sample Size": 156,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Rural",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 9.4,
    "95% CI (%)": "2.9 - 15.9",
    "Sample Size": 160,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 3.2,
    "95% CI (%)": "0.0 - 7.4",
    "Sample Size": 67,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 13.1,
    "95% CI (%)": "4.0 - 22.3",
    "Sample Size": 131,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 30.6,
    "95% CI (%)": "7.0 - 54.2",
    "Sample Size": 104,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "1.0 - 2.1",
    "Sample Size": 213,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.5,
    "95% CI (%)": "4.3 - 12.6",
    "Sample Size": 680,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.4,
    "95% CI (%)": "1.6 - 7.3",
    "Sample Size": 615,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.6 - 2.6",
    "Sample Size": 1238,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Low SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.8,
    "95% CI (%)": "1.0 - 6.7",
    "Sample Size": 230,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "2.7 - 5.2",
    "Sample Size": 2379,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.7,
    "95% CI (%)": "0.0 - 3.9",
    "Sample Size": 78,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.4,
    "95% CI (%)": "0.0 - 1.2",
    "Sample Size": 106,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1,
    "95% CI (%)": "0.3 - 1.7",
    "Sample Size": 233,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 7.1,
    "95% CI (%)": "1.8 - 12.4",
    "Sample Size": 134,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.1,
    "95% CI (%)": "2.8 - 5.4",
    "Sample Size": 2296,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.6,
    "95% CI (%)": "1.2 - 6.1",
    "Sample Size": 401,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.4,
    "95% CI (%)": "2.7 - 6.1",
    "Sample Size": 1714,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.7,
    "95% CI (%)": "1.4 - 7.9",
    "Sample Size": 264,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.6,
    "95% CI (%)": "1.2 - 4.0",
    "Sample Size": 637,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is a little difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.2,
    "95% CI (%)": "0.0 - 2.6",
    "Sample Size": 158,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.5,
    "95% CI (%)": "0.1 - 1.0",
    "Sample Size": 1015,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.1,
    "95% CI (%)": "0.0 - 2.4",
    "Sample Size": 174,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.5,
    "95% CI (%)": "3.1 - 5.9",
    "Sample Size": 2149,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "Spanish",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.4,
    "95% CI (%)": "0.0 - 0.9",
    "Sample Size": 311,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.4,
    "95% CI (%)": "1.2 - 7.7",
    "Sample Size": 215,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.2,
    "95% CI (%)": "1.4 - 5.0",
    "Sample Size": 501,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 7.1,
    "95% CI (%)": "3.7 - 10.5",
    "Sample Size": 614,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.3,
    "95% CI (%)": "0.0 - 0.6",
    "Sample Size": 745,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.1,
    "95% CI (%)": "1.6 - 4.6",
    "Sample Size": 1454,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.5,
    "95% CI (%)": "1.1 - 3.9",
    "Sample Size": 757,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Worse than other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.1,
    "95% CI (%)": "0.0 - 6.4",
    "Sample Size": 83,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.7,
    "95% CI (%)": "2.7 - 6.8",
    "Sample Size": 1236,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Asian, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.5,
    "95% CI (%)": "0.7 - 10.2",
    "Sample Size": 131,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.5,
    "95% CI (%)": "3.1 - 5.9",
    "Sample Size": 2149,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.3,
    "95% CI (%)": "0.0 - 5.8",
    "Sample Size": 271,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.8,
    "95% CI (%)": "1.4 - 6.3",
    "Sample Size": 198,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.4,
    "95% CI (%)": "1.0 - 3.8",
    "Sample Size": 1385,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.4,
    "95% CI (%)": "1.4 - 3.4",
    "Sample Size": 2061,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.7,
    "95% CI (%)": "4.6 - 8.9",
    "Sample Size": 1380,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4,
    "95% CI (%)": "2.8 - 5.2",
    "Sample Size": 2353,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.6,
    "95% CI (%)": "3.9 - 7.4",
    "Sample Size": 1700,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4,
    "95% CI (%)": "2.8 - 5.3",
    "Sample Size": 2374,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.7,
    "95% CI (%)": "3.1 - 6.2",
    "Sample Size": 1827,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.1,
    "95% CI (%)": "2.8 - 5.4",
    "Sample Size": 2296,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.6,
    "95% CI (%)": "1.2 - 4.0",
    "Sample Size": 637,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.4,
    "95% CI (%)": "0.0 - 1.3",
    "Sample Size": 101,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "2.7 - 5.2",
    "Sample Size": 2379,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3,
    "95% CI (%)": "1.8 - 4.2",
    "Sample Size": 1834,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant, trying to get pregnant, or breastfeeding",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.9,
    "95% CI (%)": "0.3 - 1.6",
    "Sample Size": 525,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 12,
    "95% CI (%)": "6.5 - 17.4",
    "Sample Size": 395,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.9,
    "95% CI (%)": "3.4 - 8.4",
    "Sample Size": 943,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 12,
    "95% CI (%)": "6.5 - 17.4",
    "Sample Size": 395,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 32,
    "95% CI (%)": "8.5 - 55.5",
    "Sample Size": 62,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.4,
    "95% CI (%)": "0.0 - 1.2",
    "Sample Size": 106,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 28.4,
    "95% CI (%)": "19.6 - 37.1",
    "Sample Size": 341,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.7,
    "95% CI (%)": "0.3 - 1.2",
    "Sample Size": 2127,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.0 - 3.6",
    "Sample Size": 546,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.7,
    "95% CI (%)": "0.0 - 1.8",
    "Sample Size": 161,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "1.9 - 6.0",
    "Sample Size": 946,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.1,
    "95% CI (%)": "2.8 - 5.3",
    "Sample Size": 2324,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.1,
    "95% CI (%)": "0.0 - 0.5",
    "Sample Size": 31,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "2.4 - 5.4",
    "Sample Size": 1398,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 13.4,
    "95% CI (%)": "8.1 - 18.7",
    "Sample Size": 597,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Low SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.8,
    "95% CI (%)": "1.0 - 6.7",
    "Sample Size": 230,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 11.8,
    "95% CI (%)": "5.7 - 17.9",
    "Sample Size": 345,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.7,
    "95% CI (%)": "3.1 - 6.2",
    "Sample Size": 1827,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.9,
    "95% CI (%)": "3.1 - 6.7",
    "Sample Size": 1018,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.6,
    "95% CI (%)": "0.0 - 8.5",
    "Sample Size": 62,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.7,
    "95% CI (%)": "2.5 - 5.0",
    "Sample Size": 2197,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.1,
    "95% CI (%)": "1.3 - 8.9",
    "Sample Size": 268,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.2,
    "95% CI (%)": "1.4 - 5.0",
    "Sample Size": 501,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.3,
    "95% CI (%)": "0.0 - 5.8",
    "Sample Size": 271,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.9,
    "95% CI (%)": "3.1 - 6.7",
    "Sample Size": 1018,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.6,
    "95% CI (%)": "3.9 - 7.4",
    "Sample Size": 1700,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 7.5,
    "95% CI (%)": "3.8 - 11.1",
    "Sample Size": 473,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.7,
    "95% CI (%)": "1.2 - 12.2",
    "Sample Size": 256,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.3,
    "95% CI (%)": "3.0 - 5.7",
    "Sample Size": 2130,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.1,
    "95% CI (%)": "0.0 - 2.4",
    "Sample Size": 174,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.9,
    "95% CI (%)": "3.1 - 6.7",
    "Sample Size": 1018,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "Spanish",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.4,
    "95% CI (%)": "0.0 - 0.9",
    "Sample Size": 311,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3,
    "95% CI (%)": "1.8 - 4.2",
    "Sample Size": 1236,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant, trying to get pregnant, or breastfeeding",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.9,
    "95% CI (%)": "0.3 - 1.6",
    "Sample Size": 525,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.3,
    "95% CI (%)": "1.3 - 5.3",
    "Sample Size": 412,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.9,
    "95% CI (%)": "4.8 - 9.0",
    "Sample Size": 1361,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is a little difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.2,
    "95% CI (%)": "0.0 - 2.6",
    "Sample Size": 158,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 7.1,
    "95% CI (%)": "1.8 - 12.4",
    "Sample Size": 134,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4,
    "95% CI (%)": "2.8 - 5.3",
    "Sample Size": 2339,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is somewhat difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.9,
    "95% CI (%)": "0.0 - 2.3",
    "Sample Size": 102,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.9,
    "95% CI (%)": "3.4 - 8.4",
    "Sample Size": 943,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is somewhat difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.9,
    "95% CI (%)": "0.0 - 2.3",
    "Sample Size": 102,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.5,
    "95% CI (%)": "0.1 - 1.0",
    "Sample Size": 1015,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "2.7 - 5.2",
    "Sample Size": 2379,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 13.4,
    "95% CI (%)": "8.1 - 18.7",
    "Sample Size": 597,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.4,
    "95% CI (%)": "0.0 - 1.3",
    "Sample Size": 101,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.0 - 3.6",
    "Sample Size": 546,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.4,
    "95% CI (%)": "0.0 - 1.2",
    "Sample Size": 106,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.8,
    "95% CI (%)": "2.7 - 5.0",
    "Sample Size": 2472,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.7,
    "95% CI (%)": "0.0 - 1.8",
    "Sample Size": 161,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.0 - 3.6",
    "Sample Size": 546,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 28.5,
    "95% CI (%)": "16.7 - 40.4",
    "Sample Size": 214,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 13.4,
    "95% CI (%)": "8.1 - 18.7",
    "Sample Size": 597,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.2,
    "95% CI (%)": "1.4 - 5.0",
    "Sample Size": 501,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.7,
    "95% CI (%)": "2.7 - 6.8",
    "Sample Size": 1236,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Asian, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.5,
    "95% CI (%)": "0.7 - 10.2",
    "Sample Size": 131,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.3,
    "95% CI (%)": "0.0 - 0.6",
    "Sample Size": 745,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 7.1,
    "95% CI (%)": "3.7 - 10.5",
    "Sample Size": 614,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is a little difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.2,
    "95% CI (%)": "0.0 - 2.6",
    "Sample Size": 158,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.4,
    "95% CI (%)": "1.2 - 7.7",
    "Sample Size": 215,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is somewhat difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.9,
    "95% CI (%)": "0.0 - 2.3",
    "Sample Size": 102,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.9,
    "95% CI (%)": "3.1 - 6.7",
    "Sample Size": 1018,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.9,
    "95% CI (%)": "3.4 - 8.4",
    "Sample Size": 943,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Worse than other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.1,
    "95% CI (%)": "0.0 - 6.4",
    "Sample Size": 83,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.1,
    "95% CI (%)": "1.3 - 8.9",
    "Sample Size": 268,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Asian, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.5,
    "95% CI (%)": "0.7 - 10.2",
    "Sample Size": 131,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is somewhat difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.9,
    "95% CI (%)": "0.0 - 2.3",
    "Sample Size": 102,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.4,
    "95% CI (%)": "1.2 - 7.7",
    "Sample Size": 215,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.9,
    "95% CI (%)": "3.1 - 6.7",
    "Sample Size": 1018,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.5,
    "95% CI (%)": "3.1 - 5.9",
    "Sample Size": 2149,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4,
    "95% CI (%)": "2.8 - 5.2",
    "Sample Size": 2353,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.7,
    "95% CI (%)": "0.0 - 3.9",
    "Sample Size": 78,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.8,
    "95% CI (%)": "2.7 - 5.0",
    "Sample Size": 2472,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.6,
    "95% CI (%)": "0.0 - 1.7",
    "Sample Size": 71,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4,
    "95% CI (%)": "2.8 - 5.2",
    "Sample Size": 2353,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4,
    "95% CI (%)": "2.8 - 5.3",
    "Sample Size": 2339,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.7,
    "95% CI (%)": "1.2 - 12.2",
    "Sample Size": 256,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.1,
    "95% CI (%)": "0.6 - 3.6",
    "Sample Size": 536,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.6 - 2.6",
    "Sample Size": 409,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1,
    "95% CI (%)": "0.0 - 3.1",
    "Sample Size": 79,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.4,
    "95% CI (%)": "1.2 - 7.7",
    "Sample Size": 215,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.9,
    "95% CI (%)": "3.1 - 6.7",
    "Sample Size": 1018,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.7,
    "95% CI (%)": "1.4 - 7.9",
    "Sample Size": 264,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.6,
    "95% CI (%)": "3.9 - 7.4",
    "Sample Size": 1700,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3,
    "95% CI (%)": "1.8 - 4.2",
    "Sample Size": 1236,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.6,
    "95% CI (%)": "0.0 - 8.5",
    "Sample Size": 62,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4,
    "95% CI (%)": "2.8 - 5.2",
    "Sample Size": 2353,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.1,
    "95% CI (%)": "0.0 - 0.5",
    "Sample Size": 31,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.6,
    "95% CI (%)": "1.2 - 6.1",
    "Sample Size": 401,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.1,
    "95% CI (%)": "0.0 - 0.5",
    "Sample Size": 31,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.6 - 2.6",
    "Sample Size": 409,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.7,
    "95% CI (%)": "0.0 - 3.9",
    "Sample Size": 78,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Rural",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3,
    "95% CI (%)": "0.4 - 5.6",
    "Sample Size": 128,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.6 - 2.6",
    "Sample Size": 1238,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.4,
    "95% CI (%)": "1.6 - 7.3",
    "Sample Size": 615,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.1,
    "95% CI (%)": "2.8 - 5.3",
    "Sample Size": 2324,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 28.4,
    "95% CI (%)": "19.6 - 37.1",
    "Sample Size": 341,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1,
    "95% CI (%)": "0.3 - 1.7",
    "Sample Size": 233,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.5,
    "95% CI (%)": "3.1 - 5.9",
    "Sample Size": 2149,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "Spanish",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.4,
    "95% CI (%)": "0.0 - 0.9",
    "Sample Size": 311,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.5,
    "95% CI (%)": "1.1 - 3.9",
    "Sample Size": 757,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.1,
    "95% CI (%)": "0.6 - 3.6",
    "Sample Size": 536,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1,
    "95% CI (%)": "0.0 - 3.1",
    "Sample Size": 79,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.2,
    "95% CI (%)": "2.8 - 5.6",
    "Sample Size": 2076,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.6,
    "95% CI (%)": "0.0 - 8.5",
    "Sample Size": 62,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6,
    "95% CI (%)": "4.0 - 8.1",
    "Sample Size": 1077,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4,
    "95% CI (%)": "2.8 - 5.3",
    "Sample Size": 2374,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Rural",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3,
    "95% CI (%)": "0.4 - 5.6",
    "Sample Size": 128,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.2,
    "95% CI (%)": "2.8 - 5.6",
    "Sample Size": 2076,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.7,
    "95% CI (%)": "2.5 - 5.0",
    "Sample Size": 2197,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.2,
    "95% CI (%)": "2.8 - 5.6",
    "Sample Size": 2076,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.1,
    "95% CI (%)": "1.6 - 4.6",
    "Sample Size": 1454,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1,
    "95% CI (%)": "0.0 - 3.1",
    "Sample Size": 79,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.8,
    "95% CI (%)": "3.3 - 6.3",
    "Sample Size": 2064,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "2.4 - 5.4",
    "Sample Size": 1398,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4,
    "95% CI (%)": "2.8 - 5.3",
    "Sample Size": 2339,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.6 - 2.6",
    "Sample Size": 1238,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.4,
    "95% CI (%)": "0.0 - 1.2",
    "Sample Size": 106,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "1.9 - 6.0",
    "Sample Size": 946,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.8,
    "95% CI (%)": "2.7 - 5.0",
    "Sample Size": 2472,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.6,
    "95% CI (%)": "0.0 - 1.7",
    "Sample Size": 71,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4,
    "95% CI (%)": "2.8 - 5.2",
    "Sample Size": 2353,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.4,
    "95% CI (%)": "2.7 - 6.1",
    "Sample Size": 1714,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Rural",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3,
    "95% CI (%)": "0.4 - 5.6",
    "Sample Size": 128,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Low SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.8,
    "95% CI (%)": "1.0 - 6.7",
    "Sample Size": 230,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1,
    "95% CI (%)": "0.3 - 1.7",
    "Sample Size": 233,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 32,
    "95% CI (%)": "8.5 - 55.5",
    "Sample Size": 62,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.6,
    "95% CI (%)": "1.2 - 4.0",
    "Sample Size": 637,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.7,
    "95% CI (%)": "0.0 - 3.9",
    "Sample Size": 78,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 7.1,
    "95% CI (%)": "1.8 - 12.4",
    "Sample Size": 134,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.7,
    "95% CI (%)": "1.4 - 7.9",
    "Sample Size": 264,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.1,
    "95% CI (%)": "2.8 - 5.4",
    "Sample Size": 2296,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 28.4,
    "95% CI (%)": "19.6 - 37.1",
    "Sample Size": 341,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.1,
    "95% CI (%)": "2.8 - 5.3",
    "Sample Size": 2324,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 11.8,
    "95% CI (%)": "5.7 - 17.9",
    "Sample Size": 345,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.7,
    "95% CI (%)": "0.3 - 1.2",
    "Sample Size": 2127,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.7,
    "95% CI (%)": "0.0 - 1.8",
    "Sample Size": 161,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 28.5,
    "95% CI (%)": "16.7 - 40.4",
    "Sample Size": 214,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.4,
    "95% CI (%)": "1.6 - 7.3",
    "Sample Size": 615,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.7,
    "95% CI (%)": "3.1 - 6.2",
    "Sample Size": 1827,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4,
    "95% CI (%)": "2.8 - 5.2",
    "Sample Size": 2353,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.4,
    "95% CI (%)": "0.0 - 1.3",
    "Sample Size": 101,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "2.7 - 5.2",
    "Sample Size": 2379,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4,
    "95% CI (%)": "2.8 - 5.3",
    "Sample Size": 2339,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "2.4 - 5.4",
    "Sample Size": 1398,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Low SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.8,
    "95% CI (%)": "1.0 - 6.7",
    "Sample Size": 230,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "1.9 - 6.0",
    "Sample Size": 946,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.6,
    "95% CI (%)": "1.2 - 6.1",
    "Sample Size": 401,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 32,
    "95% CI (%)": "8.5 - 55.5",
    "Sample Size": 62,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.6,
    "95% CI (%)": "1.2 - 4.0",
    "Sample Size": 637,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 11.8,
    "95% CI (%)": "5.7 - 17.9",
    "Sample Size": 345,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.6 - 2.6",
    "Sample Size": 409,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.4,
    "95% CI (%)": "2.7 - 6.1",
    "Sample Size": 1714,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.7,
    "95% CI (%)": "0.3 - 1.2",
    "Sample Size": 2127,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 7.1,
    "95% CI (%)": "1.8 - 12.4",
    "Sample Size": 134,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.7,
    "95% CI (%)": "1.4 - 7.9",
    "Sample Size": 264,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.1,
    "95% CI (%)": "2.8 - 5.4",
    "Sample Size": 2296,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.7,
    "95% CI (%)": "3.1 - 6.2",
    "Sample Size": 1827,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Not insured",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.1,
    "95% CI (%)": "0.0 - 0.2",
    "Sample Size": 336,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.3,
    "95% CI (%)": "0.0 - 5.8",
    "Sample Size": 271,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3,
    "95% CI (%)": "1.8 - 4.2",
    "Sample Size": 1236,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.9,
    "95% CI (%)": "3.4 - 8.4",
    "Sample Size": 943,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.9,
    "95% CI (%)": "3.1 - 6.7",
    "Sample Size": 1018,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.7,
    "95% CI (%)": "1.2 - 12.2",
    "Sample Size": 256,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.2,
    "95% CI (%)": "2.8 - 5.6",
    "Sample Size": 2076,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.8,
    "95% CI (%)": "1.4 - 6.3",
    "Sample Size": 198,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.9,
    "95% CI (%)": "0.3 - 3.4",
    "Sample Size": 913,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.1,
    "95% CI (%)": "1.3 - 8.9",
    "Sample Size": 268,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Worse than other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.1,
    "95% CI (%)": "0.0 - 6.4",
    "Sample Size": 83,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant, trying to get pregnant, or breastfeeding",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.9,
    "95% CI (%)": "0.3 - 1.6",
    "Sample Size": 525,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.1,
    "95% CI (%)": "0.0 - 2.4",
    "Sample Size": 174,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 12,
    "95% CI (%)": "6.5 - 17.4",
    "Sample Size": 395,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 7.5,
    "95% CI (%)": "3.8 - 11.1",
    "Sample Size": 473,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.9,
    "95% CI (%)": "4.8 - 9.0",
    "Sample Size": 1361,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.9,
    "95% CI (%)": "0.0 - 2.0",
    "Sample Size": 1088,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3,
    "95% CI (%)": "1.8 - 4.2",
    "Sample Size": 1834,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.7,
    "95% CI (%)": "2.5 - 5.0",
    "Sample Size": 2197,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.3,
    "95% CI (%)": "1.3 - 5.3",
    "Sample Size": 412,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.1,
    "95% CI (%)": "1.6 - 4.6",
    "Sample Size": 1454,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.5,
    "95% CI (%)": "0.1 - 1.0",
    "Sample Size": 1015,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.6,
    "95% CI (%)": "3.9 - 7.4",
    "Sample Size": 1700,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.7,
    "95% CI (%)": "4.6 - 8.9",
    "Sample Size": 1380,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6,
    "95% CI (%)": "4.0 - 8.1",
    "Sample Size": 1077,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.2,
    "95% CI (%)": "1.4 - 5.0",
    "Sample Size": 501,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Not insured",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.1,
    "95% CI (%)": "0.0 - 0.2",
    "Sample Size": 336,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.9,
    "95% CI (%)": "0.0 - 2.0",
    "Sample Size": 1088,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 12,
    "95% CI (%)": "6.5 - 17.4",
    "Sample Size": 395,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.8,
    "95% CI (%)": "1.4 - 6.3",
    "Sample Size": 198,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.6,
    "95% CI (%)": "1.2 - 6.1",
    "Sample Size": 401,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "1.9 - 6.0",
    "Sample Size": 946,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.8,
    "95% CI (%)": "1.4 - 6.3",
    "Sample Size": 198,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.9,
    "95% CI (%)": "0.3 - 3.4",
    "Sample Size": 913,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Not insured",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.1,
    "95% CI (%)": "0.0 - 0.2",
    "Sample Size": 336,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.7,
    "95% CI (%)": "0.0 - 1.8",
    "Sample Size": 161,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.3,
    "95% CI (%)": "0.0 - 0.6",
    "Sample Size": 745,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.3,
    "95% CI (%)": "3.0 - 5.7",
    "Sample Size": 2130,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.7,
    "95% CI (%)": "1.2 - 12.2",
    "Sample Size": 256,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.9,
    "95% CI (%)": "0.3 - 3.4",
    "Sample Size": 913,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.4,
    "95% CI (%)": "1.0 - 3.8",
    "Sample Size": 1385,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4,
    "95% CI (%)": "2.8 - 5.3",
    "Sample Size": 2374,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.9,
    "95% CI (%)": "0.3 - 3.4",
    "Sample Size": 913,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.7,
    "95% CI (%)": "1.2 - 12.2",
    "Sample Size": 256,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.6,
    "95% CI (%)": "0.0 - 1.7",
    "Sample Size": 71,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.4,
    "95% CI (%)": "1.4 - 3.4",
    "Sample Size": 2061,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.3,
    "95% CI (%)": "3.0 - 5.7",
    "Sample Size": 2130,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.7,
    "95% CI (%)": "1.2 - 12.2",
    "Sample Size": 256,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.7,
    "95% CI (%)": "2.7 - 6.8",
    "Sample Size": 1236,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant, trying to get pregnant, or breastfeeding",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.9,
    "95% CI (%)": "0.3 - 1.6",
    "Sample Size": 525,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.3,
    "95% CI (%)": "3.0 - 5.7",
    "Sample Size": 2130,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1,
    "95% CI (%)": "0.3 - 1.7",
    "Sample Size": 233,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.1,
    "95% CI (%)": "0.0 - 0.5",
    "Sample Size": 31,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4,
    "95% CI (%)": "2.8 - 5.2",
    "Sample Size": 2353,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3,
    "95% CI (%)": "1.8 - 4.2",
    "Sample Size": 1236,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.9,
    "95% CI (%)": "0.3 - 3.4",
    "Sample Size": 913,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.3,
    "95% CI (%)": "0.0 - 0.6",
    "Sample Size": 745,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.1,
    "95% CI (%)": "0.6 - 3.6",
    "Sample Size": 536,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.8,
    "95% CI (%)": "3.3 - 6.3",
    "Sample Size": 2064,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "Spanish",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.4,
    "95% CI (%)": "0.0 - 0.9",
    "Sample Size": 311,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.9,
    "95% CI (%)": "3.1 - 6.7",
    "Sample Size": 1018,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.9,
    "95% CI (%)": "0.3 - 3.4",
    "Sample Size": 913,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.3,
    "95% CI (%)": "0.0 - 5.8",
    "Sample Size": 271,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.7,
    "95% CI (%)": "2.5 - 5.0",
    "Sample Size": 2197,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 7.1,
    "95% CI (%)": "3.7 - 10.5",
    "Sample Size": 614,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3,
    "95% CI (%)": "1.8 - 4.2",
    "Sample Size": 1834,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.3,
    "95% CI (%)": "1.3 - 5.3",
    "Sample Size": 412,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.9,
    "95% CI (%)": "4.8 - 9.0",
    "Sample Size": 1361,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.1,
    "95% CI (%)": "0.0 - 2.4",
    "Sample Size": 174,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 7.5,
    "95% CI (%)": "3.8 - 11.1",
    "Sample Size": 473,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.1,
    "95% CI (%)": "1.6 - 4.6",
    "Sample Size": 1454,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.5,
    "95% CI (%)": "1.1 - 3.9",
    "Sample Size": 757,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.5,
    "95% CI (%)": "0.1 - 1.0",
    "Sample Size": 1015,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.4,
    "95% CI (%)": "1.0 - 3.8",
    "Sample Size": 1385,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.4,
    "95% CI (%)": "1.4 - 3.4",
    "Sample Size": 2061,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.7,
    "95% CI (%)": "4.6 - 8.9",
    "Sample Size": 1380,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.9,
    "95% CI (%)": "0.3 - 3.4",
    "Sample Size": 913,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.7,
    "95% CI (%)": "1.2 - 12.2",
    "Sample Size": 256,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is a little difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.2,
    "95% CI (%)": "0.0 - 2.6",
    "Sample Size": 158,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.6 - 2.6",
    "Sample Size": 1238,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.8,
    "95% CI (%)": "3.3 - 6.3",
    "Sample Size": 2064,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 28.4,
    "95% CI (%)": "19.6 - 37.1",
    "Sample Size": 341,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6,
    "95% CI (%)": "4.0 - 8.1",
    "Sample Size": 1077,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.3,
    "95% CI (%)": "1.3 - 5.3",
    "Sample Size": 412,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "2.4 - 5.4",
    "Sample Size": 1398,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.7,
    "95% CI (%)": "2.7 - 6.8",
    "Sample Size": 1236,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.4,
    "95% CI (%)": "1.4 - 3.4",
    "Sample Size": 2061,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.7,
    "95% CI (%)": "4.6 - 8.9",
    "Sample Size": 1380,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.9,
    "95% CI (%)": "0.3 - 3.4",
    "Sample Size": 913,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 7.5,
    "95% CI (%)": "3.8 - 11.1",
    "Sample Size": 473,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.4,
    "95% CI (%)": "2.7 - 6.1",
    "Sample Size": 1714,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Rural",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3,
    "95% CI (%)": "0.4 - 5.6",
    "Sample Size": 128,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 11.8,
    "95% CI (%)": "5.7 - 17.9",
    "Sample Size": 345,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 13.4,
    "95% CI (%)": "8.1 - 18.7",
    "Sample Size": 597,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.4,
    "95% CI (%)": "0.0 - 1.3",
    "Sample Size": 101,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.6 - 2.6",
    "Sample Size": 409,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 28.5,
    "95% CI (%)": "16.7 - 40.4",
    "Sample Size": 214,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4,
    "95% CI (%)": "2.8 - 5.2",
    "Sample Size": 2353,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.8,
    "95% CI (%)": "2.7 - 5.0",
    "Sample Size": 2472,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.1,
    "95% CI (%)": "2.8 - 5.3",
    "Sample Size": 2324,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.7,
    "95% CI (%)": "0.3 - 1.2",
    "Sample Size": 2127,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.0 - 3.6",
    "Sample Size": 546,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 32,
    "95% CI (%)": "8.5 - 55.5",
    "Sample Size": 62,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 28.5,
    "95% CI (%)": "16.7 - 40.4",
    "Sample Size": 214,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.4,
    "95% CI (%)": "1.6 - 7.3",
    "Sample Size": 615,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.5,
    "95% CI (%)": "1.1 - 3.9",
    "Sample Size": 757,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Asian, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.5,
    "95% CI (%)": "0.7 - 10.2",
    "Sample Size": 131,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.9,
    "95% CI (%)": "4.8 - 9.0",
    "Sample Size": 1361,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Worse than other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.1,
    "95% CI (%)": "0.0 - 6.4",
    "Sample Size": 83,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 7.1,
    "95% CI (%)": "3.7 - 10.5",
    "Sample Size": 614,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.9,
    "95% CI (%)": "0.0 - 2.0",
    "Sample Size": 1088,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.6,
    "95% CI (%)": "0.0 - 1.7",
    "Sample Size": 71,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.4,
    "95% CI (%)": "1.0 - 3.8",
    "Sample Size": 1385,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4,
    "95% CI (%)": "2.8 - 5.3",
    "Sample Size": 2374,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Not insured",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.1,
    "95% CI (%)": "0.0 - 0.2",
    "Sample Size": 336,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.1,
    "95% CI (%)": "0.6 - 3.6",
    "Sample Size": 536,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.1,
    "95% CI (%)": "1.3 - 8.9",
    "Sample Size": 268,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.6,
    "95% CI (%)": "0.0 - 8.5",
    "Sample Size": 62,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.8,
    "95% CI (%)": "3.3 - 6.3",
    "Sample Size": 2064,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.7,
    "95% CI (%)": "1.2 - 12.2",
    "Sample Size": 256,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3,
    "95% CI (%)": "1.8 - 4.2",
    "Sample Size": 1834,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.9,
    "95% CI (%)": "0.0 - 2.0",
    "Sample Size": 1088,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6,
    "95% CI (%)": "4.0 - 8.1",
    "Sample Size": 1077,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1,
    "95% CI (%)": "0.0 - 3.1",
    "Sample Size": 79,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.5,
    "95% CI (%)": "4.7 - 8.4",
    "Sample Size": 2428,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 19.2,
    "95% CI (%)": "15.6 - 22.9",
    "Sample Size": 2283,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 0.7,
    "95% CI (%)": "0.2 - 1.3",
    "Sample Size": 1287,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.5,
    "95% CI (%)": "13.3 - 21.6",
    "Sample Size": 1731,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.6,
    "95% CI (%)": "13.6 - 19.6",
    "Sample Size": 2838,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 2.4,
    "95% CI (%)": "1.2 - 3.7",
    "Sample Size": 1748,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.5,
    "95% CI (%)": "6.3 - 10.7",
    "Sample Size": 2399,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.8,
    "95% CI (%)": "4.0 - 11.5",
    "Sample Size": 835,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 18.6,
    "95% CI (%)": "15.1 - 22.1",
    "Sample Size": 2405,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 13.5,
    "95% CI (%)": "7.9 - 19.0",
    "Sample Size": 755,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Worse than other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.2,
    "95% CI (%)": "0.0 - 17.2",
    "Sample Size": 135,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 2.3,
    "95% CI (%)": "1.1 - 3.5",
    "Sample Size": 1746,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 15.1,
    "95% CI (%)": "9.6 - 20.6",
    "Sample Size": 794,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 32.2,
    "95% CI (%)": "24.9 - 39.6",
    "Sample Size": 827,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.4,
    "95% CI (%)": "9.4 - 15.3",
    "Sample Size": 2074,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.8,
    "95% CI (%)": "13.2 - 22.4",
    "Sample Size": 1085,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.4,
    "95% CI (%)": "8.3 - 12.5",
    "Sample Size": 3457,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.4,
    "95% CI (%)": "5.9 - 16.8",
    "Sample Size": 462,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.8,
    "95% CI (%)": "2.4 - 15.3",
    "Sample Size": 318,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.2,
    "95% CI (%)": "2.6 - 13.8",
    "Sample Size": 444,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.9,
    "95% CI (%)": "5.9 - 10.0",
    "Sample Size": 3043,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.6,
    "95% CI (%)": "4.4 - 18.7",
    "Sample Size": 348,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.4,
    "95% CI (%)": "8.3 - 12.5",
    "Sample Size": 3699,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.4,
    "95% CI (%)": "1.0 - 9.9",
    "Sample Size": 129,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 9.7,
    "95% CI (%)": "5.4 - 14.0",
    "Sample Size": 842,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.6,
    "95% CI (%)": "9.5 - 15.7",
    "Sample Size": 1766,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.4,
    "95% CI (%)": "6.0 - 10.9",
    "Sample Size": 2099,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.4,
    "95% CI (%)": "4.3 - 12.4",
    "Sample Size": 448,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.2,
    "95% CI (%)": "5.1 - 11.4",
    "Sample Size": 1480,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Asian, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.1,
    "95% CI (%)": "3.6 - 28.5",
    "Sample Size": 207,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.1,
    "95% CI (%)": "9.9 - 14.4",
    "Sample Size": 3519,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.5,
    "95% CI (%)": "9.3 - 13.7",
    "Sample Size": 3735,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Not insured",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 1.9,
    "95% CI (%)": "0.1 - 3.8",
    "Sample Size": 524,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12,
    "95% CI (%)": "8.3 - 15.7",
    "Sample Size": 1206,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.3,
    "95% CI (%)": "7.3 - 13.3",
    "Sample Size": 1681,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "Spanish",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 3.1,
    "95% CI (%)": "0.4 - 5.8",
    "Sample Size": 420,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.7,
    "95% CI (%)": "4.2 - 11.3",
    "Sample Size": 840,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.3,
    "95% CI (%)": "9.0 - 13.6",
    "Sample Size": 3131,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 44.4,
    "95% CI (%)": "32.0 - 56.8",
    "Sample Size": 411,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.1,
    "95% CI (%)": "8.0 - 16.3",
    "Sample Size": 1109,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 38,
    "95% CI (%)": "31.6 - 44.4",
    "Sample Size": 1203,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 2.4,
    "95% CI (%)": "1.3 - 3.6",
    "Sample Size": 2960,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11,
    "95% CI (%)": "9.0 - 13.1",
    "Sample Size": 3994,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 0.6,
    "95% CI (%)": "0.0 - 1.2",
    "Sample Size": 112,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 13,
    "95% CI (%)": "6.3 - 19.7",
    "Sample Size": 293,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.7,
    "95% CI (%)": "2.8 - 10.6",
    "Sample Size": 838,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.6,
    "95% CI (%)": "0.0 - 12.1",
    "Sample Size": 258,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.3,
    "95% CI (%)": "9.2 - 13.3",
    "Sample Size": 3941,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11,
    "95% CI (%)": "8.9 - 13.0",
    "Sample Size": 3887,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.1,
    "95% CI (%)": "3.9 - 18.3",
    "Sample Size": 349,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.7,
    "95% CI (%)": "3.1 - 12.2",
    "Sample Size": 454,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 26.6,
    "95% CI (%)": "18.5 - 34.6",
    "Sample Size": 632,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 22.1,
    "95% CI (%)": "16.5 - 27.6",
    "Sample Size": 1141,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.1,
    "95% CI (%)": "9.1 - 15.1",
    "Sample Size": 2452,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Rural",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 9.4,
    "95% CI (%)": "2.9 - 15.9",
    "Sample Size": 160,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 2.2,
    "95% CI (%)": "0.0 - 4.5",
    "Sample Size": 164,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.3,
    "95% CI (%)": "0.0 - 12.5",
    "Sample Size": 125,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.1,
    "95% CI (%)": "4.8 - 9.5",
    "Sample Size": 1997,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.5,
    "95% CI (%)": "0.0 - 11.9",
    "Sample Size": 160,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.8,
    "95% CI (%)": "8.8 - 12.8",
    "Sample Size": 3973,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.9,
    "95% CI (%)": "8.9 - 12.9",
    "Sample Size": 3990,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.9,
    "95% CI (%)": "8.9 - 12.9",
    "Sample Size": 4013,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is very difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 0.3,
    "95% CI (%)": "0.0 - 0.8",
    "Sample Size": 100,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is a little difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.5,
    "95% CI (%)": "0.0 - 13.0",
    "Sample Size": 283,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 2.9,
    "95% CI (%)": "0.0 - 7.0",
    "Sample Size": 142,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.8,
    "95% CI (%)": "8.8 - 12.8",
    "Sample Size": 4018,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.0 - 3.5",
    "Sample Size": 143,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.4,
    "95% CI (%)": "9.2 - 13.6",
    "Sample Size": 3623,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.6,
    "95% CI (%)": "9.5 - 15.7",
    "Sample Size": 1766,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.4,
    "95% CI (%)": "4.3 - 12.4",
    "Sample Size": 448,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is somewhat difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.8,
    "95% CI (%)": "1.1 - 22.4",
    "Sample Size": 127,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.8,
    "95% CI (%)": "3.8 - 17.9",
    "Sample Size": 369,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.2,
    "95% CI (%)": "4.6 - 7.8",
    "Sample Size": 3310,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.2,
    "95% CI (%)": "5.1 - 11.4",
    "Sample Size": 1480,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 15.9,
    "95% CI (%)": "0.0 - 36.9",
    "Sample Size": 31,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 0.5,
    "95% CI (%)": "0.0 - 1.3",
    "Sample Size": 31,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.3,
    "95% CI (%)": "6.6 - 14.0",
    "Sample Size": 1035,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.4,
    "95% CI (%)": "8.5 - 12.4",
    "Sample Size": 4173,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Low SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 13.5,
    "95% CI (%)": "6.2 - 20.7",
    "Sample Size": 156,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.7,
    "95% CI (%)": "8.3 - 13.1",
    "Sample Size": 3339,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 9.4,
    "95% CI (%)": "6.7 - 12.2",
    "Sample Size": 1561,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 9.7,
    "95% CI (%)": "5.2 - 14.1",
    "Sample Size": 453,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 3.2,
    "95% CI (%)": "0.0 - 7.4",
    "Sample Size": 67,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 13.1,
    "95% CI (%)": "4.0 - 22.3",
    "Sample Size": 131,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 30.6,
    "95% CI (%)": "7.0 - 54.2",
    "Sample Size": 104,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "1.0 - 2.1",
    "Sample Size": 213,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.5,
    "95% CI (%)": "4.3 - 12.6",
    "Sample Size": 680,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 6.7,
    "95% CI (%)": "0.0 - 14.4",
    "Sample Size": 156,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 2.5,
    "95% CI (%)": "0.0 - 5.1",
    "Sample Size": 134,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 3,
    "95% CI (%)": "0.0 - 6.2",
    "Sample Size": 187,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is very difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 4.9,
    "95% CI (%)": "0.0 - 13.2",
    "Sample Size": 94,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 3.8,
    "95% CI (%)": "0.0 - 8.1",
    "Sample Size": 151,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13,
    "95% CI (%)": "10.6 - 15.3",
    "Sample Size": 3756,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 7.7,
    "95% CI (%)": "0.0 - 16.6",
    "Sample Size": 101,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13.3,
    "95% CI (%)": "10.9 - 15.7",
    "Sample Size": 3684,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13.1,
    "95% CI (%)": "10.7 - 15.5",
    "Sample Size": 3653,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 6.9,
    "95% CI (%)": "0.0 - 16.8",
    "Sample Size": 160,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 12.9,
    "95% CI (%)": "10.5 - 15.2",
    "Sample Size": 3713,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 12.9,
    "95% CI (%)": "10.5 - 15.3",
    "Sample Size": 3718,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 6.2,
    "95% CI (%)": "0.0 - 12.9",
    "Sample Size": 234,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 47.2,
    "95% CI (%)": "32.9 - 61.4",
    "Sample Size": 415,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 31.4,
    "95% CI (%)": "25.7 - 37.1",
    "Sample Size": 1657,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 3.2,
    "95% CI (%)": "1.7 - 4.8",
    "Sample Size": 2252,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 19.3,
    "95% CI (%)": "12.6 - 26.0",
    "Sample Size": 948,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 42.7,
    "95% CI (%)": "14.0 - 71.4",
    "Sample Size": 33,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 12.4,
    "95% CI (%)": "4.9 - 19.8",
    "Sample Size": 73,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 6.5,
    "95% CI (%)": "3.1 - 9.9",
    "Sample Size": 614,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13.7,
    "95% CI (%)": "6.7 - 20.7",
    "Sample Size": 411,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 31.5,
    "95% CI (%)": "20.8 - 42.3",
    "Sample Size": 571,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 20.3,
    "95% CI (%)": "1.9 - 38.6",
    "Sample Size": 128,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 10.6,
    "95% CI (%)": "0.0 - 23.0",
    "Sample Size": 110,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 10.1,
    "95% CI (%)": "4.5 - 15.7",
    "Sample Size": 205,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 28.7,
    "95% CI (%)": "18.3 - 39.0",
    "Sample Size": 241,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 8.4,
    "95% CI (%)": "5.0 - 11.8",
    "Sample Size": 821,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 11.7,
    "95% CI (%)": "3.0 - 20.4",
    "Sample Size": 336,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 12.5,
    "95% CI (%)": "10.2 - 14.7",
    "Sample Size": 3915,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 12.3,
    "95% CI (%)": "7.5 - 17.0",
    "Sample Size": 950,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 7.7,
    "95% CI (%)": "5.4 - 10.0",
    "Sample Size": 1918,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 29.1,
    "95% CI (%)": "21.4 - 36.8",
    "Sample Size": 1047,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 15.4,
    "95% CI (%)": "11.7 - 19.2",
    "Sample Size": 2561,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 12.1,
    "95% CI (%)": "9.0 - 15.3",
    "Sample Size": 1286,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 14.3,
    "95% CI (%)": "9.0 - 19.7",
    "Sample Size": 340,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Low SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 14.8,
    "95% CI (%)": "4.0 - 25.5",
    "Sample Size": 65,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Rural",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 4,
    "95% CI (%)": "0.3 - 7.6",
    "Sample Size": 68,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13.5,
    "95% CI (%)": "8.3 - 18.6",
    "Sample Size": 808,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 12.2,
    "95% CI (%)": "9.7 - 14.7",
    "Sample Size": 2910,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 11.6,
    "95% CI (%)": "9.1 - 14.0",
    "Sample Size": 3300,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13,
    "95% CI (%)": "8.7 - 17.4",
    "Sample Size": 1109,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 12.7,
    "95% CI (%)": "9.3 - 16.0",
    "Sample Size": 1529,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "Other",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 8.2,
    "95% CI (%)": "0.0 - 22.4",
    "Sample Size": 33,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Not insured",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 7.6,
    "95% CI (%)": "2.8 - 12.4",
    "Sample Size": 496,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 11.9,
    "95% CI (%)": "9.7 - 14.2",
    "Sample Size": 3454,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13.6,
    "95% CI (%)": "11.1 - 16.1",
    "Sample Size": 3292,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "Spanish",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 16.4,
    "95% CI (%)": "8.1 - 24.6",
    "Sample Size": 428,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13,
    "95% CI (%)": "5.7 - 20.3",
    "Sample Size": 452,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 14.3,
    "95% CI (%)": "10.5 - 18.0",
    "Sample Size": 1596,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 10.8,
    "95% CI (%)": "6.6 - 14.9",
    "Sample Size": 825,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 11.1,
    "95% CI (%)": "8.3 - 13.8",
    "Sample Size": 1989,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 10.7,
    "95% CI (%)": "7.1 - 14.2",
    "Sample Size": 1398,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Asian, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 7.3,
    "95% CI (%)": "2.6 - 11.9",
    "Sample Size": 211,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 12.7,
    "95% CI (%)": "6.5 - 18.8",
    "Sample Size": 443,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 18.4,
    "95% CI (%)": "6.6 - 30.3",
    "Sample Size": 131,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 19.9,
    "95% CI (%)": "10.7 - 29.0",
    "Sample Size": 458,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 9.9,
    "95% CI (%)": "7.6 - 12.2",
    "Sample Size": 2895,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 12.1,
    "95% CI (%)": "4.5 - 19.6",
    "Sample Size": 342,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 20.7,
    "95% CI (%)": "14.8 - 26.6",
    "Sample Size": 979,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 11.9,
    "95% CI (%)": "9.6 - 14.3",
    "Sample Size": 3230,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 17.9,
    "95% CI (%)": "10.5 - 25.3",
    "Sample Size": 298,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13.8,
    "95% CI (%)": "10.3 - 17.3",
    "Sample Size": 1926,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 2.4,
    "95% CI (%)": "1.1 - 3.7",
    "Sample Size": 1596,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 11.4,
    "95% CI (%)": "9.2 - 13.5",
    "Sample Size": 3447,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 7.6,
    "95% CI (%)": "4.4 - 10.9",
    "Sample Size": 863,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13.9,
    "95% CI (%)": "8.4 - 19.4",
    "Sample Size": 667,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Worse than other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 15.5,
    "95% CI (%)": "0.0 - 32.9",
    "Sample Size": 149,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 10.8,
    "95% CI (%)": "8.2 - 13.3",
    "Sample Size": 2232,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 21.3,
    "95% CI (%)": "17.4 - 25.3",
    "Sample Size": 2289,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 15.8,
    "95% CI (%)": "10.2 - 21.4",
    "Sample Size": 777,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 21.4,
    "95% CI (%)": "17.4 - 25.4",
    "Sample Size": 2181,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 0.4,
    "95% CI (%)": "0.2 - 0.6",
    "Sample Size": 1189,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 8.9,
    "95% CI (%)": "6.6 - 11.1",
    "Sample Size": 3011,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 20.7,
    "95% CI (%)": "15.9 - 25.6",
    "Sample Size": 1597,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 7.8,
    "95% CI (%)": "5.6 - 10.0",
    "Sample Size": 2298,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 19.6,
    "95% CI (%)": "16.2 - 23.1",
    "Sample Size": 2687,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 31.9,
    "95% CI (%)": "24.1 - 39.8",
    "Sample Size": 869,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is a little difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 9.8,
    "95% CI (%)": "1.3 - 18.3",
    "Sample Size": 271,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is somewhat difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 1.5,
    "95% CI (%)": "0.7 - 2.3",
    "Sample Size": 144,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "1.9 - 6.0",
    "Sample Size": 1620,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13.7,
    "95% CI (%)": "11.1 - 16.3",
    "Sample Size": 3370,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 11.2,
    "95% CI (%)": "5.8 - 16.6",
    "Sample Size": 370,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 10.7,
    "95% CI (%)": "7.1 - 14.2",
    "Sample Size": 1398,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 12.7,
    "95% CI (%)": "6.5 - 18.8",
    "Sample Size": 443,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 14.3,
    "95% CI (%)": "10.5 - 18.0",
    "Sample Size": 1596,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 6.7,
    "95% CI (%)": "0.0 - 14.4",
    "Sample Size": 156,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 12.9,
    "95% CI (%)": "10.6 - 15.3",
    "Sample Size": 3741,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 3.8,
    "95% CI (%)": "0.0 - 8.1",
    "Sample Size": 151,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 2.5,
    "95% CI (%)": "0.0 - 5.1",
    "Sample Size": 134,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13,
    "95% CI (%)": "10.6 - 15.3",
    "Sample Size": 3756,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is very difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 4.9,
    "95% CI (%)": "0.0 - 13.2",
    "Sample Size": 94,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 3,
    "95% CI (%)": "0.0 - 6.2",
    "Sample Size": 187,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13.2,
    "95% CI (%)": "10.7 - 15.6",
    "Sample Size": 3707,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 6.9,
    "95% CI (%)": "0.0 - 16.8",
    "Sample Size": 160,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 6.2,
    "95% CI (%)": "0.0 - 12.9",
    "Sample Size": 234,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 7.7,
    "95% CI (%)": "0.0 - 16.6",
    "Sample Size": 101,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 12.9,
    "95% CI (%)": "10.5 - 15.3",
    "Sample Size": 3718,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13.3,
    "95% CI (%)": "10.9 - 15.7",
    "Sample Size": 3684,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 12.9,
    "95% CI (%)": "10.5 - 15.2",
    "Sample Size": 3713,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 47.2,
    "95% CI (%)": "32.9 - 61.4",
    "Sample Size": 415,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13.1,
    "95% CI (%)": "10.7 - 15.5",
    "Sample Size": 3653,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 3.2,
    "95% CI (%)": "1.7 - 4.8",
    "Sample Size": 2252,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 19.3,
    "95% CI (%)": "12.6 - 26.0",
    "Sample Size": 948,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 31.4,
    "95% CI (%)": "25.7 - 37.1",
    "Sample Size": 1657,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 42.7,
    "95% CI (%)": "14.0 - 71.4",
    "Sample Size": 33,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 12.4,
    "95% CI (%)": "4.9 - 19.8",
    "Sample Size": 73,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13.7,
    "95% CI (%)": "6.7 - 20.7",
    "Sample Size": 411,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 31.5,
    "95% CI (%)": "20.8 - 42.3",
    "Sample Size": 571,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 6.5,
    "95% CI (%)": "3.1 - 9.9",
    "Sample Size": 614,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 20.3,
    "95% CI (%)": "1.9 - 38.6",
    "Sample Size": 128,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 10.6,
    "95% CI (%)": "0.0 - 23.0",
    "Sample Size": 110,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 10.1,
    "95% CI (%)": "4.5 - 15.7",
    "Sample Size": 205,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 28.7,
    "95% CI (%)": "18.3 - 39.0",
    "Sample Size": 241,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 8.4,
    "95% CI (%)": "5.0 - 11.8",
    "Sample Size": 821,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 11.7,
    "95% CI (%)": "3.0 - 20.4",
    "Sample Size": 336,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 12.3,
    "95% CI (%)": "7.5 - 17.0",
    "Sample Size": 950,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 12.5,
    "95% CI (%)": "10.2 - 14.7",
    "Sample Size": 3915,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 7.7,
    "95% CI (%)": "5.4 - 10.0",
    "Sample Size": 1918,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 15.4,
    "95% CI (%)": "11.7 - 19.2",
    "Sample Size": 2561,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 29.1,
    "95% CI (%)": "21.4 - 36.8",
    "Sample Size": 1047,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Rural",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 4,
    "95% CI (%)": "0.3 - 7.6",
    "Sample Size": 68,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 14.3,
    "95% CI (%)": "9.0 - 19.7",
    "Sample Size": 340,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Low SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 14.8,
    "95% CI (%)": "4.0 - 25.5",
    "Sample Size": 65,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 12.1,
    "95% CI (%)": "9.0 - 15.3",
    "Sample Size": 1286,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13.5,
    "95% CI (%)": "8.3 - 18.6",
    "Sample Size": 808,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 11.6,
    "95% CI (%)": "9.1 - 14.0",
    "Sample Size": 3300,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 12.2,
    "95% CI (%)": "9.7 - 14.7",
    "Sample Size": 2910,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13,
    "95% CI (%)": "8.7 - 17.4",
    "Sample Size": 1109,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13.6,
    "95% CI (%)": "11.1 - 16.1",
    "Sample Size": 3292,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Not insured",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 7.6,
    "95% CI (%)": "2.8 - 12.4",
    "Sample Size": 496,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "Spanish",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 16.4,
    "95% CI (%)": "8.1 - 24.6",
    "Sample Size": 428,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "Other",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 8.2,
    "95% CI (%)": "0.0 - 22.4",
    "Sample Size": 33,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 12.7,
    "95% CI (%)": "9.3 - 16.0",
    "Sample Size": 1529,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 11.9,
    "95% CI (%)": "9.7 - 14.2",
    "Sample Size": 3454,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 11.1,
    "95% CI (%)": "8.3 - 13.8",
    "Sample Size": 1989,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 10.7,
    "95% CI (%)": "7.1 - 14.2",
    "Sample Size": 1398,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 18.4,
    "95% CI (%)": "6.6 - 30.3",
    "Sample Size": 131,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 10.8,
    "95% CI (%)": "6.6 - 14.9",
    "Sample Size": 825,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13,
    "95% CI (%)": "5.7 - 20.3",
    "Sample Size": 452,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 14.3,
    "95% CI (%)": "10.5 - 18.0",
    "Sample Size": 1596,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Asian, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 7.3,
    "95% CI (%)": "2.6 - 11.9",
    "Sample Size": 211,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 12.7,
    "95% CI (%)": "6.5 - 18.8",
    "Sample Size": 443,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 19.9,
    "95% CI (%)": "10.7 - 29.0",
    "Sample Size": 458,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 9.9,
    "95% CI (%)": "7.6 - 12.2",
    "Sample Size": 2895,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 20.7,
    "95% CI (%)": "14.8 - 26.6",
    "Sample Size": 979,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 17.9,
    "95% CI (%)": "10.5 - 25.3",
    "Sample Size": 298,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 12.1,
    "95% CI (%)": "4.5 - 19.6",
    "Sample Size": 342,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 11.9,
    "95% CI (%)": "9.6 - 14.3",
    "Sample Size": 3230,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13.8,
    "95% CI (%)": "10.3 - 17.3",
    "Sample Size": 1926,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Worse than other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 15.5,
    "95% CI (%)": "0.0 - 32.9",
    "Sample Size": 149,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 11.4,
    "95% CI (%)": "9.2 - 13.5",
    "Sample Size": 3447,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 10.8,
    "95% CI (%)": "8.2 - 13.3",
    "Sample Size": 2232,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 2.4,
    "95% CI (%)": "1.1 - 3.7",
    "Sample Size": 1596,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 21.3,
    "95% CI (%)": "17.4 - 25.3",
    "Sample Size": 2289,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 7.6,
    "95% CI (%)": "4.4 - 10.9",
    "Sample Size": 863,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 15.8,
    "95% CI (%)": "10.2 - 21.4",
    "Sample Size": 777,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13.9,
    "95% CI (%)": "8.4 - 19.4",
    "Sample Size": 667,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 21.4,
    "95% CI (%)": "17.4 - 25.4",
    "Sample Size": 2181,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 31.9,
    "95% CI (%)": "24.1 - 39.8",
    "Sample Size": 869,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 0.4,
    "95% CI (%)": "0.2 - 0.6",
    "Sample Size": 1189,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 7.8,
    "95% CI (%)": "5.6 - 10.0",
    "Sample Size": 2298,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 19.6,
    "95% CI (%)": "16.2 - 23.1",
    "Sample Size": 2687,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 20.7,
    "95% CI (%)": "15.9 - 25.6",
    "Sample Size": 1597,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 8.9,
    "95% CI (%)": "6.6 - 11.1",
    "Sample Size": 3011,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "1.9 - 6.0",
    "Sample Size": 1620,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 11.2,
    "95% CI (%)": "5.8 - 16.6",
    "Sample Size": 370,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 10.7,
    "95% CI (%)": "7.1 - 14.2",
    "Sample Size": 1398,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 14.3,
    "95% CI (%)": "10.5 - 18.0",
    "Sample Size": 1596,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is somewhat difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 1.5,
    "95% CI (%)": "0.7 - 2.3",
    "Sample Size": 144,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13.7,
    "95% CI (%)": "11.1 - 16.3",
    "Sample Size": 3370,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is a little difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 9.8,
    "95% CI (%)": "1.3 - 18.3",
    "Sample Size": 271,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 12.7,
    "95% CI (%)": "6.5 - 18.8",
    "Sample Size": 443,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13.2,
    "95% CI (%)": "10.7 - 15.6",
    "Sample Size": 3707,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 12.9,
    "95% CI (%)": "10.6 - 15.3",
    "Sample Size": 3741,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.5,
    "95% CI (%)": "4.7 - 8.4",
    "Sample Size": 2428,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.2,
    "95% CI (%)": "4.6 - 7.8",
    "Sample Size": 3310,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 2.4,
    "95% CI (%)": "1.2 - 3.7",
    "Sample Size": 1748,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.6,
    "95% CI (%)": "13.6 - 19.6",
    "Sample Size": 2838,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.5,
    "95% CI (%)": "13.3 - 21.6",
    "Sample Size": 1731,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 32.2,
    "95% CI (%)": "24.9 - 39.6",
    "Sample Size": 827,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 13.5,
    "95% CI (%)": "7.9 - 19.0",
    "Sample Size": 755,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.8,
    "95% CI (%)": "4.0 - 11.5",
    "Sample Size": 835,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 18.6,
    "95% CI (%)": "15.1 - 22.1",
    "Sample Size": 2405,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.5,
    "95% CI (%)": "6.3 - 10.7",
    "Sample Size": 2399,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Worse than other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.2,
    "95% CI (%)": "0.0 - 17.2",
    "Sample Size": 135,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 2.3,
    "95% CI (%)": "1.1 - 3.5",
    "Sample Size": 1746,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 15.1,
    "95% CI (%)": "9.6 - 20.6",
    "Sample Size": 794,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.8,
    "95% CI (%)": "13.2 - 22.4",
    "Sample Size": 1085,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.8,
    "95% CI (%)": "2.4 - 15.3",
    "Sample Size": 318,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.4,
    "95% CI (%)": "5.9 - 16.8",
    "Sample Size": 462,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.4,
    "95% CI (%)": "8.3 - 12.5",
    "Sample Size": 3457,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.4,
    "95% CI (%)": "9.4 - 15.3",
    "Sample Size": 2074,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.9,
    "95% CI (%)": "5.9 - 10.0",
    "Sample Size": 3043,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.6,
    "95% CI (%)": "4.4 - 18.7",
    "Sample Size": 348,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.4,
    "95% CI (%)": "8.3 - 12.5",
    "Sample Size": 3699,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.4,
    "95% CI (%)": "1.0 - 9.9",
    "Sample Size": 129,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 9.7,
    "95% CI (%)": "5.4 - 14.0",
    "Sample Size": 842,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Asian, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.1,
    "95% CI (%)": "3.6 - 28.5",
    "Sample Size": 207,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.2,
    "95% CI (%)": "5.1 - 11.4",
    "Sample Size": 1480,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.6,
    "95% CI (%)": "9.5 - 15.7",
    "Sample Size": 1766,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.4,
    "95% CI (%)": "4.3 - 12.4",
    "Sample Size": 448,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.2,
    "95% CI (%)": "2.6 - 13.8",
    "Sample Size": 444,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.4,
    "95% CI (%)": "6.0 - 10.9",
    "Sample Size": 2099,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.3,
    "95% CI (%)": "7.3 - 13.3",
    "Sample Size": 1681,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.5,
    "95% CI (%)": "9.3 - 13.7",
    "Sample Size": 3735,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12,
    "95% CI (%)": "8.3 - 15.7",
    "Sample Size": 1206,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.1,
    "95% CI (%)": "9.9 - 14.4",
    "Sample Size": 3519,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "Spanish",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 3.1,
    "95% CI (%)": "0.4 - 5.8",
    "Sample Size": 420,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Not insured",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 1.9,
    "95% CI (%)": "0.1 - 3.8",
    "Sample Size": 524,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.7,
    "95% CI (%)": "4.2 - 11.3",
    "Sample Size": 840,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.7,
    "95% CI (%)": "8.3 - 13.1",
    "Sample Size": 3339,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.3,
    "95% CI (%)": "9.0 - 13.6",
    "Sample Size": 3131,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 44.4,
    "95% CI (%)": "32.0 - 56.8",
    "Sample Size": 411,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 2.4,
    "95% CI (%)": "1.3 - 3.6",
    "Sample Size": 2960,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11,
    "95% CI (%)": "9.0 - 13.1",
    "Sample Size": 3994,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 38,
    "95% CI (%)": "31.6 - 44.4",
    "Sample Size": 1203,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.1,
    "95% CI (%)": "8.0 - 16.3",
    "Sample Size": 1109,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 13,
    "95% CI (%)": "6.3 - 19.7",
    "Sample Size": 293,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 0.6,
    "95% CI (%)": "0.0 - 1.2",
    "Sample Size": 112,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.6,
    "95% CI (%)": "0.0 - 12.1",
    "Sample Size": 258,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.7,
    "95% CI (%)": "2.8 - 10.6",
    "Sample Size": 838,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11,
    "95% CI (%)": "8.9 - 13.0",
    "Sample Size": 3887,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.3,
    "95% CI (%)": "9.2 - 13.3",
    "Sample Size": 3941,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.7,
    "95% CI (%)": "3.1 - 12.2",
    "Sample Size": 454,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.1,
    "95% CI (%)": "3.9 - 18.3",
    "Sample Size": 349,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 26.6,
    "95% CI (%)": "18.5 - 34.6",
    "Sample Size": 632,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.1,
    "95% CI (%)": "9.1 - 15.1",
    "Sample Size": 2452,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 22.1,
    "95% CI (%)": "16.5 - 27.6",
    "Sample Size": 1141,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 9.4,
    "95% CI (%)": "6.7 - 12.2",
    "Sample Size": 1561,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 2.9,
    "95% CI (%)": "0.0 - 7.0",
    "Sample Size": 142,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 2.2,
    "95% CI (%)": "0.0 - 4.5",
    "Sample Size": 164,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.1,
    "95% CI (%)": "4.8 - 9.5",
    "Sample Size": 1997,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.8,
    "95% CI (%)": "8.8 - 12.8",
    "Sample Size": 4018,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.9,
    "95% CI (%)": "8.9 - 12.9",
    "Sample Size": 3990,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.0 - 3.5",
    "Sample Size": 143,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.8,
    "95% CI (%)": "8.8 - 12.8",
    "Sample Size": 3973,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.9,
    "95% CI (%)": "8.9 - 12.9",
    "Sample Size": 4013,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.5,
    "95% CI (%)": "0.0 - 11.9",
    "Sample Size": 160,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.3,
    "95% CI (%)": "0.0 - 12.5",
    "Sample Size": 125,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is a little difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.5,
    "95% CI (%)": "0.0 - 13.0",
    "Sample Size": 283,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.4,
    "95% CI (%)": "4.3 - 12.4",
    "Sample Size": 448,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is somewhat difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.8,
    "95% CI (%)": "1.1 - 22.4",
    "Sample Size": 127,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.6,
    "95% CI (%)": "9.5 - 15.7",
    "Sample Size": 1766,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.4,
    "95% CI (%)": "9.2 - 13.6",
    "Sample Size": 3623,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.8,
    "95% CI (%)": "3.8 - 17.9",
    "Sample Size": 369,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 19.2,
    "95% CI (%)": "15.6 - 22.9",
    "Sample Size": 2283,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 0.7,
    "95% CI (%)": "0.2 - 1.3",
    "Sample Size": 1287,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.2,
    "95% CI (%)": "5.1 - 11.4",
    "Sample Size": 1480,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is very difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 0.3,
    "95% CI (%)": "0.0 - 0.8",
    "Sample Size": 100,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 15.9,
    "95% CI (%)": "0.0 - 36.9",
    "Sample Size": 31,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 0.5,
    "95% CI (%)": "0.0 - 1.3",
    "Sample Size": 31,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.3,
    "95% CI (%)": "6.6 - 14.0",
    "Sample Size": 1035,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.4,
    "95% CI (%)": "8.5 - 12.4",
    "Sample Size": 4173,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 9.7,
    "95% CI (%)": "5.2 - 14.1",
    "Sample Size": 453,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Low SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 13.5,
    "95% CI (%)": "6.2 - 20.7",
    "Sample Size": 156,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Rural",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 9.4,
    "95% CI (%)": "2.9 - 15.9",
    "Sample Size": 160,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 3.2,
    "95% CI (%)": "0.0 - 7.4",
    "Sample Size": 67,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 13.1,
    "95% CI (%)": "4.0 - 22.3",
    "Sample Size": 131,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 30.6,
    "95% CI (%)": "7.0 - 54.2",
    "Sample Size": 104,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "1.0 - 2.1",
    "Sample Size": 213,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.5,
    "95% CI (%)": "4.3 - 12.6",
    "Sample Size": 680,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.5,
    "95% CI (%)": "4.7 - 8.4",
    "Sample Size": 2428,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 19.2,
    "95% CI (%)": "15.6 - 22.9",
    "Sample Size": 2283,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 0.7,
    "95% CI (%)": "0.2 - 1.3",
    "Sample Size": 1287,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.5,
    "95% CI (%)": "13.3 - 21.6",
    "Sample Size": 1731,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.6,
    "95% CI (%)": "13.6 - 19.6",
    "Sample Size": 2838,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 2.4,
    "95% CI (%)": "1.2 - 3.7",
    "Sample Size": 1748,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.5,
    "95% CI (%)": "6.3 - 10.7",
    "Sample Size": 2399,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.8,
    "95% CI (%)": "4.0 - 11.5",
    "Sample Size": 835,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 18.6,
    "95% CI (%)": "15.1 - 22.1",
    "Sample Size": 2405,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 13.5,
    "95% CI (%)": "7.9 - 19.0",
    "Sample Size": 755,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Worse than other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.2,
    "95% CI (%)": "0.0 - 17.2",
    "Sample Size": 135,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 2.3,
    "95% CI (%)": "1.1 - 3.5",
    "Sample Size": 1746,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 15.1,
    "95% CI (%)": "9.6 - 20.6",
    "Sample Size": 794,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 32.2,
    "95% CI (%)": "24.9 - 39.6",
    "Sample Size": 827,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.4,
    "95% CI (%)": "9.4 - 15.3",
    "Sample Size": 2074,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.8,
    "95% CI (%)": "13.2 - 22.4",
    "Sample Size": 1085,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.4,
    "95% CI (%)": "8.3 - 12.5",
    "Sample Size": 3457,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.4,
    "95% CI (%)": "5.9 - 16.8",
    "Sample Size": 462,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.8,
    "95% CI (%)": "2.4 - 15.3",
    "Sample Size": 318,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.2,
    "95% CI (%)": "2.6 - 13.8",
    "Sample Size": 444,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.9,
    "95% CI (%)": "5.9 - 10.0",
    "Sample Size": 3043,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.6,
    "95% CI (%)": "4.4 - 18.7",
    "Sample Size": 348,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.4,
    "95% CI (%)": "8.3 - 12.5",
    "Sample Size": 3699,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.4,
    "95% CI (%)": "1.0 - 9.9",
    "Sample Size": 129,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 9.7,
    "95% CI (%)": "5.4 - 14.0",
    "Sample Size": 842,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.6,
    "95% CI (%)": "9.5 - 15.7",
    "Sample Size": 1766,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.4,
    "95% CI (%)": "6.0 - 10.9",
    "Sample Size": 2099,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.4,
    "95% CI (%)": "4.3 - 12.4",
    "Sample Size": 448,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.2,
    "95% CI (%)": "5.1 - 11.4",
    "Sample Size": 1480,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Asian, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.1,
    "95% CI (%)": "3.6 - 28.5",
    "Sample Size": 207,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.1,
    "95% CI (%)": "9.9 - 14.4",
    "Sample Size": 3519,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.5,
    "95% CI (%)": "9.3 - 13.7",
    "Sample Size": 3735,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Not insured",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 1.9,
    "95% CI (%)": "0.1 - 3.8",
    "Sample Size": 524,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12,
    "95% CI (%)": "8.3 - 15.7",
    "Sample Size": 1206,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.3,
    "95% CI (%)": "7.3 - 13.3",
    "Sample Size": 1681,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "Spanish",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 3.1,
    "95% CI (%)": "0.4 - 5.8",
    "Sample Size": 420,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.7,
    "95% CI (%)": "4.2 - 11.3",
    "Sample Size": 840,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.3,
    "95% CI (%)": "9.0 - 13.6",
    "Sample Size": 3131,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 44.4,
    "95% CI (%)": "32.0 - 56.8",
    "Sample Size": 411,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.1,
    "95% CI (%)": "8.0 - 16.3",
    "Sample Size": 1109,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 38,
    "95% CI (%)": "31.6 - 44.4",
    "Sample Size": 1203,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 2.4,
    "95% CI (%)": "1.3 - 3.6",
    "Sample Size": 2960,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11,
    "95% CI (%)": "9.0 - 13.1",
    "Sample Size": 3994,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 0.6,
    "95% CI (%)": "0.0 - 1.2",
    "Sample Size": 112,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 13,
    "95% CI (%)": "6.3 - 19.7",
    "Sample Size": 293,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.7,
    "95% CI (%)": "2.8 - 10.6",
    "Sample Size": 838,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.6,
    "95% CI (%)": "0.0 - 12.1",
    "Sample Size": 258,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.3,
    "95% CI (%)": "9.2 - 13.3",
    "Sample Size": 3941,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11,
    "95% CI (%)": "8.9 - 13.0",
    "Sample Size": 3887,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.1,
    "95% CI (%)": "3.9 - 18.3",
    "Sample Size": 349,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.7,
    "95% CI (%)": "3.1 - 12.2",
    "Sample Size": 454,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 26.6,
    "95% CI (%)": "18.5 - 34.6",
    "Sample Size": 632,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 22.1,
    "95% CI (%)": "16.5 - 27.6",
    "Sample Size": 1141,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.1,
    "95% CI (%)": "9.1 - 15.1",
    "Sample Size": 2452,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Rural",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 9.4,
    "95% CI (%)": "2.9 - 15.9",
    "Sample Size": 160,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 2.2,
    "95% CI (%)": "0.0 - 4.5",
    "Sample Size": 164,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.3,
    "95% CI (%)": "0.0 - 12.5",
    "Sample Size": 125,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.1,
    "95% CI (%)": "4.8 - 9.5",
    "Sample Size": 1997,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.5,
    "95% CI (%)": "0.0 - 11.9",
    "Sample Size": 160,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.8,
    "95% CI (%)": "8.8 - 12.8",
    "Sample Size": 3973,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.9,
    "95% CI (%)": "8.9 - 12.9",
    "Sample Size": 3990,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.9,
    "95% CI (%)": "8.9 - 12.9",
    "Sample Size": 4013,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is very difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 0.3,
    "95% CI (%)": "0.0 - 0.8",
    "Sample Size": 100,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is a little difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.5,
    "95% CI (%)": "0.0 - 13.0",
    "Sample Size": 283,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 2.9,
    "95% CI (%)": "0.0 - 7.0",
    "Sample Size": 142,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.8,
    "95% CI (%)": "8.8 - 12.8",
    "Sample Size": 4018,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.0 - 3.5",
    "Sample Size": 143,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.4,
    "95% CI (%)": "9.2 - 13.6",
    "Sample Size": 3623,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.6,
    "95% CI (%)": "9.5 - 15.7",
    "Sample Size": 1766,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.4,
    "95% CI (%)": "4.3 - 12.4",
    "Sample Size": 448,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is somewhat difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.8,
    "95% CI (%)": "1.1 - 22.4",
    "Sample Size": 127,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.8,
    "95% CI (%)": "3.8 - 17.9",
    "Sample Size": 369,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.2,
    "95% CI (%)": "4.6 - 7.8",
    "Sample Size": 3310,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.2,
    "95% CI (%)": "5.1 - 11.4",
    "Sample Size": 1480,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 15.9,
    "95% CI (%)": "0.0 - 36.9",
    "Sample Size": 31,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 0.5,
    "95% CI (%)": "0.0 - 1.3",
    "Sample Size": 31,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.3,
    "95% CI (%)": "6.6 - 14.0",
    "Sample Size": 1035,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.4,
    "95% CI (%)": "8.5 - 12.4",
    "Sample Size": 4173,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Low SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 13.5,
    "95% CI (%)": "6.2 - 20.7",
    "Sample Size": 156,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.7,
    "95% CI (%)": "8.3 - 13.1",
    "Sample Size": 3339,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 9.4,
    "95% CI (%)": "6.7 - 12.2",
    "Sample Size": 1561,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 9.7,
    "95% CI (%)": "5.2 - 14.1",
    "Sample Size": 453,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 3.2,
    "95% CI (%)": "0.0 - 7.4",
    "Sample Size": 67,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 13.1,
    "95% CI (%)": "4.0 - 22.3",
    "Sample Size": 131,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 30.6,
    "95% CI (%)": "7.0 - 54.2",
    "Sample Size": 104,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "1.0 - 2.1",
    "Sample Size": 213,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 8.5,
    "95% CI (%)": "4.3 - 12.6",
    "Sample Size": 680,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 33.3,
    "95% CI (%)": "4.4 - 62.2",
    "Sample Size": 80,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 38.5,
    "95% CI (%)": "14.3 - 62.7",
    "Sample Size": 89,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 4.9,
    "95% CI (%)": "0.0 - 10.4",
    "Sample Size": 139,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 18,
    "95% CI (%)": "8.3 - 27.6",
    "Sample Size": 251,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 11.7,
    "95% CI (%)": "5.6 - 17.8",
    "Sample Size": 459,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 34.3,
    "95% CI (%)": "22.2 - 46.4",
    "Sample Size": 393,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 10.1,
    "95% CI (%)": "4.6 - 15.6",
    "Sample Size": 490,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 41.4,
    "95% CI (%)": "18.6 - 64.2",
    "Sample Size": 159,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17.6,
    "95% CI (%)": "1.8 - 33.4",
    "Sample Size": 177,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 16.4,
    "95% CI (%)": "13.2 - 19.7",
    "Sample Size": 2506,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 20.1,
    "95% CI (%)": "12.5 - 27.6",
    "Sample Size": 578,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 10.4,
    "95% CI (%)": "6.8 - 13.9",
    "Sample Size": 1250,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 19.8,
    "95% CI (%)": "14.4 - 25.2",
    "Sample Size": 1565,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 32.4,
    "95% CI (%)": "23.1 - 41.8",
    "Sample Size": 678,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Low SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17.3,
    "95% CI (%)": "3.5 - 31.1",
    "Sample Size": 80,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Rural",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 6.4,
    "95% CI (%)": "0.0 - 13.5",
    "Sample Size": 78,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 15.6,
    "95% CI (%)": "11.1 - 20.2",
    "Sample Size": 863,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 13.6,
    "95% CI (%)": "7.9 - 19.3",
    "Sample Size": 282,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17.4,
    "95% CI (%)": "13.8 - 21.1",
    "Sample Size": 1958,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 18,
    "95% CI (%)": "13.8 - 22.2",
    "Sample Size": 2041,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 13.6,
    "95% CI (%)": "6.1 - 21.0",
    "Sample Size": 448,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Not insured",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 12.1,
    "95% CI (%)": "3.1 - 21.0",
    "Sample Size": 292,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17.6,
    "95% CI (%)": "14.0 - 21.1",
    "Sample Size": 2154,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "Spanish",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 11,
    "95% CI (%)": "0.0 - 22.5",
    "Sample Size": 173,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 16.9,
    "95% CI (%)": "13.5 - 20.3",
    "Sample Size": 2319,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Asian, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 18.4,
    "95% CI (%)": "0.0 - 37.2",
    "Sample Size": 112,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 9.6,
    "95% CI (%)": "3.0 - 16.1",
    "Sample Size": 243,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 18.1,
    "95% CI (%)": "12.9 - 23.4",
    "Sample Size": 1033,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 19.8,
    "95% CI (%)": "13.2 - 26.5",
    "Sample Size": 755,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 19.1,
    "95% CI (%)": "8.9 - 29.4",
    "Sample Size": 308,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 18.9,
    "95% CI (%)": "13.9 - 23.9",
    "Sample Size": 1103,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 14.2,
    "95% CI (%)": "8.7 - 19.7",
    "Sample Size": 826,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 12.5,
    "95% CI (%)": "6.3 - 18.7",
    "Sample Size": 475,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 16.6,
    "95% CI (%)": "6.0 - 27.2",
    "Sample Size": 264,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 11.8,
    "95% CI (%)": "8.6 - 15.1",
    "Sample Size": 1827,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 28.3,
    "95% CI (%)": "20.3 - 36.2",
    "Sample Size": 643,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 5.3,
    "95% CI (%)": "1.3 - 9.3",
    "Sample Size": 70,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 16.1,
    "95% CI (%)": "11.6 - 20.6",
    "Sample Size": 1218,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 16.4,
    "95% CI (%)": "13.0 - 19.8",
    "Sample Size": 2232,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 16.1,
    "95% CI (%)": "12.6 - 19.6",
    "Sample Size": 2097,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 16.8,
    "95% CI (%)": "12.1 - 21.4",
    "Sample Size": 1288,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 22,
    "95% CI (%)": "8.8 - 35.1",
    "Sample Size": 227,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17.9,
    "95% CI (%)": "3.1 - 32.8",
    "Sample Size": 157,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 19.3,
    "95% CI (%)": "10.9 - 27.8",
    "Sample Size": 439,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 4.4,
    "95% CI (%)": "1.4 - 7.4",
    "Sample Size": 1013,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 15.4,
    "95% CI (%)": "11.1 - 19.6",
    "Sample Size": 1415,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 27.1,
    "95% CI (%)": "21.8 - 32.4",
    "Sample Size": 1478,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Worse than other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 6.4,
    "95% CI (%)": "2.1 - 10.6",
    "Sample Size": 137,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 10,
    "95% CI (%)": "5.2 - 14.8",
    "Sample Size": 580,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 22.3,
    "95% CI (%)": "14.1 - 30.5",
    "Sample Size": 472,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 29.2,
    "95% CI (%)": "23.4 - 34.9",
    "Sample Size": 1320,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 25.6,
    "95% CI (%)": "20.8 - 30.4",
    "Sample Size": 1686,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 6.9,
    "95% CI (%)": "4.4 - 9.4",
    "Sample Size": 1469,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 31.1,
    "95% CI (%)": "24.4 - 37.8",
    "Sample Size": 1031,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 34.5,
    "95% CI (%)": "25.5 - 43.6",
    "Sample Size": 546,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.0 - 3.9",
    "Sample Size": 794,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 11.2,
    "95% CI (%)": "8.0 - 14.5",
    "Sample Size": 1933,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 18,
    "95% CI (%)": "14.4 - 21.6",
    "Sample Size": 2188,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is a little difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 3.1,
    "95% CI (%)": "1.1 - 5.2",
    "Sample Size": 138,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 18.9,
    "95% CI (%)": "13.9 - 23.9",
    "Sample Size": 1103,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 14.4,
    "95% CI (%)": "2.7 - 26.2",
    "Sample Size": 200,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 4.4,
    "95% CI (%)": "1.9 - 6.9",
    "Sample Size": 1114,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 19.1,
    "95% CI (%)": "8.9 - 29.4",
    "Sample Size": 308,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 14.2,
    "95% CI (%)": "8.7 - 19.7",
    "Sample Size": 826,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 16.3,
    "95% CI (%)": "0.0 - 42.6",
    "Sample Size": 69,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 1.2,
    "95% CI (%)": "0.0 - 2.4",
    "Sample Size": 91,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 2.2,
    "95% CI (%)": "0.4 - 4.0",
    "Sample Size": 95,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is somewhat difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 1.9,
    "95% CI (%)": "0.1 - 3.7",
    "Sample Size": 102,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17.2,
    "95% CI (%)": "13.8 - 20.6",
    "Sample Size": 2402,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 16.5,
    "95% CI (%)": "13.2 - 19.8",
    "Sample Size": 2425,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is very difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 13.7,
    "95% CI (%)": "0.0 - 40.0",
    "Sample Size": 59,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17.2,
    "95% CI (%)": "13.8 - 20.5",
    "Sample Size": 2406,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17.4,
    "95% CI (%)": "14.0 - 20.9",
    "Sample Size": 2361,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17,
    "95% CI (%)": "13.7 - 20.3",
    "Sample Size": 2379,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17,
    "95% CI (%)": "13.7 - 20.4",
    "Sample Size": 2397,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 0.9,
    "95% CI (%)": "0.0 - 1.8",
    "Sample Size": 137,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 2.2,
    "95% CI (%)": "0.3 - 4.1",
    "Sample Size": 89,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17.2,
    "95% CI (%)": "13.9 - 20.6",
    "Sample Size": 2395,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 16.1,
    "95% CI (%)": "0.0 - 44.6",
    "Sample Size": 60,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 1.8,
    "95% CI (%)": "0.2 - 3.5",
    "Sample Size": 94,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 36.6,
    "95% CI (%)": "30.0 - 43.2",
    "Sample Size": 1155,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 2.7,
    "95% CI (%)": "0.6 - 4.9",
    "Sample Size": 1349,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17,
    "95% CI (%)": "10.1 - 23.9",
    "Sample Size": 596,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 68.1,
    "95% CI (%)": "52.5 - 83.8",
    "Sample Size": 265,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 5,
    "95% CI (%)": "0.0 - 11.3",
    "Sample Size": 40,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 33.3,
    "95% CI (%)": "4.4 - 62.2",
    "Sample Size": 80,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 38.5,
    "95% CI (%)": "14.3 - 62.7",
    "Sample Size": 89,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 4.9,
    "95% CI (%)": "0.0 - 10.4",
    "Sample Size": 139,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 18,
    "95% CI (%)": "8.3 - 27.6",
    "Sample Size": 251,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 11.7,
    "95% CI (%)": "5.6 - 17.8",
    "Sample Size": 459,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 34.3,
    "95% CI (%)": "22.2 - 46.4",
    "Sample Size": 393,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 10.1,
    "95% CI (%)": "4.6 - 15.6",
    "Sample Size": 490,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17.6,
    "95% CI (%)": "1.8 - 33.4",
    "Sample Size": 177,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 41.4,
    "95% CI (%)": "18.6 - 64.2",
    "Sample Size": 159,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 16.4,
    "95% CI (%)": "13.2 - 19.7",
    "Sample Size": 2506,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 20.1,
    "95% CI (%)": "12.5 - 27.6",
    "Sample Size": 578,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 10.4,
    "95% CI (%)": "6.8 - 13.9",
    "Sample Size": 1250,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 19.8,
    "95% CI (%)": "14.4 - 25.2",
    "Sample Size": 1565,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 32.4,
    "95% CI (%)": "23.1 - 41.8",
    "Sample Size": 678,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Rural",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 6.4,
    "95% CI (%)": "0.0 - 13.5",
    "Sample Size": 78,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 13.6,
    "95% CI (%)": "7.9 - 19.3",
    "Sample Size": 282,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Low SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17.3,
    "95% CI (%)": "3.5 - 31.1",
    "Sample Size": 80,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 18,
    "95% CI (%)": "13.8 - 22.2",
    "Sample Size": 2041,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 15.6,
    "95% CI (%)": "11.1 - 20.2",
    "Sample Size": 863,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 13.6,
    "95% CI (%)": "6.1 - 21.0",
    "Sample Size": 448,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17.4,
    "95% CI (%)": "13.8 - 21.1",
    "Sample Size": 1958,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "Spanish",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 11,
    "95% CI (%)": "0.0 - 22.5",
    "Sample Size": 173,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17.6,
    "95% CI (%)": "14.0 - 21.1",
    "Sample Size": 2154,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Not insured",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 12.1,
    "95% CI (%)": "3.1 - 21.0",
    "Sample Size": 292,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 16.9,
    "95% CI (%)": "13.5 - 20.3",
    "Sample Size": 2319,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Asian, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 18.4,
    "95% CI (%)": "0.0 - 37.2",
    "Sample Size": 112,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 19.8,
    "95% CI (%)": "13.2 - 26.5",
    "Sample Size": 755,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 18.9,
    "95% CI (%)": "13.9 - 23.9",
    "Sample Size": 1103,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 14.2,
    "95% CI (%)": "8.7 - 19.7",
    "Sample Size": 826,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 12.5,
    "95% CI (%)": "6.3 - 18.7",
    "Sample Size": 475,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 19.1,
    "95% CI (%)": "8.9 - 29.4",
    "Sample Size": 308,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 18.1,
    "95% CI (%)": "12.9 - 23.4",
    "Sample Size": 1033,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 9.6,
    "95% CI (%)": "3.0 - 16.1",
    "Sample Size": 243,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 16.4,
    "95% CI (%)": "13.0 - 19.8",
    "Sample Size": 2232,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 11.8,
    "95% CI (%)": "8.6 - 15.1",
    "Sample Size": 1827,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 16.1,
    "95% CI (%)": "12.6 - 19.6",
    "Sample Size": 2097,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 22,
    "95% CI (%)": "8.8 - 35.1",
    "Sample Size": 227,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 16.8,
    "95% CI (%)": "12.1 - 21.4",
    "Sample Size": 1288,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 16.1,
    "95% CI (%)": "11.6 - 20.6",
    "Sample Size": 1218,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17.9,
    "95% CI (%)": "3.1 - 32.8",
    "Sample Size": 157,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 28.3,
    "95% CI (%)": "20.3 - 36.2",
    "Sample Size": 643,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 5.3,
    "95% CI (%)": "1.3 - 9.3",
    "Sample Size": 70,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 16.6,
    "95% CI (%)": "6.0 - 27.2",
    "Sample Size": 264,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 19.3,
    "95% CI (%)": "10.9 - 27.8",
    "Sample Size": 439,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 4.4,
    "95% CI (%)": "1.4 - 7.4",
    "Sample Size": 1013,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 15.4,
    "95% CI (%)": "11.1 - 19.6",
    "Sample Size": 1415,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 22.3,
    "95% CI (%)": "14.1 - 30.5",
    "Sample Size": 472,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Worse than other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 6.4,
    "95% CI (%)": "2.1 - 10.6",
    "Sample Size": 137,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 10,
    "95% CI (%)": "5.2 - 14.8",
    "Sample Size": 580,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 27.1,
    "95% CI (%)": "21.8 - 32.4",
    "Sample Size": 1478,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 29.2,
    "95% CI (%)": "23.4 - 34.9",
    "Sample Size": 1320,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 31.1,
    "95% CI (%)": "24.4 - 37.8",
    "Sample Size": 1031,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.0 - 3.9",
    "Sample Size": 794,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 25.6,
    "95% CI (%)": "20.8 - 30.4",
    "Sample Size": 1686,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 11.2,
    "95% CI (%)": "8.0 - 14.5",
    "Sample Size": 1933,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 6.9,
    "95% CI (%)": "4.4 - 9.4",
    "Sample Size": 1469,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 34.5,
    "95% CI (%)": "25.5 - 43.6",
    "Sample Size": 546,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 18,
    "95% CI (%)": "14.4 - 21.6",
    "Sample Size": 2188,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 14.2,
    "95% CI (%)": "8.7 - 19.7",
    "Sample Size": 826,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 14.4,
    "95% CI (%)": "2.7 - 26.2",
    "Sample Size": 200,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 4.4,
    "95% CI (%)": "1.9 - 6.9",
    "Sample Size": 1114,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is a little difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 3.1,
    "95% CI (%)": "1.1 - 5.2",
    "Sample Size": 138,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 19.1,
    "95% CI (%)": "8.9 - 29.4",
    "Sample Size": 308,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 18.9,
    "95% CI (%)": "13.9 - 23.9",
    "Sample Size": 1103,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is very difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 13.7,
    "95% CI (%)": "0.0 - 40.0",
    "Sample Size": 59,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 2.2,
    "95% CI (%)": "0.4 - 4.0",
    "Sample Size": 95,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 16.5,
    "95% CI (%)": "13.2 - 19.8",
    "Sample Size": 2425,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 1.2,
    "95% CI (%)": "0.0 - 2.4",
    "Sample Size": 91,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17.2,
    "95% CI (%)": "13.8 - 20.5",
    "Sample Size": 2406,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is somewhat difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 1.9,
    "95% CI (%)": "0.1 - 3.7",
    "Sample Size": 102,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17.2,
    "95% CI (%)": "13.8 - 20.6",
    "Sample Size": 2402,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 16.3,
    "95% CI (%)": "0.0 - 42.6",
    "Sample Size": 69,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17.4,
    "95% CI (%)": "14.0 - 20.9",
    "Sample Size": 2361,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 16.1,
    "95% CI (%)": "0.0 - 44.6",
    "Sample Size": 60,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 2.2,
    "95% CI (%)": "0.3 - 4.1",
    "Sample Size": 89,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17,
    "95% CI (%)": "13.7 - 20.4",
    "Sample Size": 2397,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17.2,
    "95% CI (%)": "13.9 - 20.6",
    "Sample Size": 2395,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17,
    "95% CI (%)": "13.7 - 20.3",
    "Sample Size": 2379,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 1.8,
    "95% CI (%)": "0.2 - 3.5",
    "Sample Size": 94,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 0.9,
    "95% CI (%)": "0.0 - 1.8",
    "Sample Size": 137,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 36.6,
    "95% CI (%)": "30.0 - 43.2",
    "Sample Size": 1155,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 2.7,
    "95% CI (%)": "0.6 - 4.9",
    "Sample Size": 1349,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17,
    "95% CI (%)": "10.1 - 23.9",
    "Sample Size": 596,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 68.1,
    "95% CI (%)": "52.5 - 83.8",
    "Sample Size": 265,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 5,
    "95% CI (%)": "0.0 - 11.3",
    "Sample Size": 40,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 40.7,
    "95% CI (%)": "0.0 - 90.5",
    "Sample Size": 31,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 18.8,
    "95% CI (%)": "0.0 - 44.4",
    "Sample Size": 78,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17.8,
    "95% CI (%)": "0.0 - 35.6",
    "Sample Size": 148,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 9.1,
    "95% CI (%)": "0.3 - 17.9",
    "Sample Size": 253,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 14.5,
    "95% CI (%)": "8.4 - 20.7",
    "Sample Size": 150,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 14.4,
    "95% CI (%)": "7.0 - 21.8",
    "Sample Size": 424,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 6.6,
    "95% CI (%)": "3.3 - 10.0",
    "Sample Size": 736,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 41,
    "95% CI (%)": "30.6 - 51.4",
    "Sample Size": 676,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 9.9,
    "95% CI (%)": "3.7 - 16.1",
    "Sample Size": 350,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 6.4,
    "95% CI (%)": "3.2 - 9.6",
    "Sample Size": 989,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 26.8,
    "95% CI (%)": "11.3 - 42.3",
    "Sample Size": 275,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.2,
    "95% CI (%)": "10.9 - 15.6",
    "Sample Size": 4538,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.4,
    "95% CI (%)": "8.7 - 18.2",
    "Sample Size": 1033,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 7.3,
    "95% CI (%)": "5.0 - 9.6",
    "Sample Size": 2309,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 33.6,
    "95% CI (%)": "25.8 - 41.3",
    "Sample Size": 1196,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 14,
    "95% CI (%)": "10.6 - 17.4",
    "Sample Size": 2973,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.4,
    "95% CI (%)": "10.0 - 16.8",
    "Sample Size": 1460,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Rural",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 9.5,
    "95% CI (%)": "3.6 - 15.4",
    "Sample Size": 105,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Low SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.6,
    "95% CI (%)": "4.0 - 23.2",
    "Sample Size": 88,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17.6,
    "95% CI (%)": "12.1 - 23.2",
    "Sample Size": 421,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 11.6,
    "95% CI (%)": "8.9 - 14.2",
    "Sample Size": 3832,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 14.9,
    "95% CI (%)": "12.0 - 17.7",
    "Sample Size": 3358,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 8.9,
    "95% CI (%)": "4.9 - 12.9",
    "Sample Size": 990,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Not insured",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 4.9,
    "95% CI (%)": "0.8 - 9.1",
    "Sample Size": 615,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 14.2,
    "95% CI (%)": "11.6 - 16.7",
    "Sample Size": 4022,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 15.5,
    "95% CI (%)": "12.7 - 18.2",
    "Sample Size": 3796,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 12.1,
    "95% CI (%)": "5.4 - 18.8",
    "Sample Size": 551,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 11.4,
    "95% CI (%)": "5.8 - 17.1",
    "Sample Size": 893,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Asian, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17.1,
    "95% CI (%)": "5.3 - 28.9",
    "Sample Size": 245,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.1,
    "95% CI (%)": "6.2 - 20.0",
    "Sample Size": 501,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "Spanish",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 7.4,
    "95% CI (%)": "1.7 - 13.0",
    "Sample Size": 492,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 11.2,
    "95% CI (%)": "7.4 - 15.0",
    "Sample Size": 1329,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 9.2,
    "95% CI (%)": "6.1 - 12.2",
    "Sample Size": 1614,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 16.1,
    "95% CI (%)": "12.1 - 20.1",
    "Sample Size": 1815,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 16.5,
    "95% CI (%)": "12.5 - 20.4",
    "Sample Size": 1836,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.8,
    "95% CI (%)": "11.1 - 16.4",
    "Sample Size": 3793,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 11.2,
    "95% CI (%)": "8.2 - 14.3",
    "Sample Size": 2301,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 18.6,
    "95% CI (%)": "9.5 - 27.8",
    "Sample Size": 377,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 22.7,
    "95% CI (%)": "1.6 - 43.8",
    "Sample Size": 133,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 4.1,
    "95% CI (%)": "0.0 - 8.1",
    "Sample Size": 321,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 15.2,
    "95% CI (%)": "11.6 - 18.7",
    "Sample Size": 2237,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 19.7,
    "95% CI (%)": "14.1 - 25.3",
    "Sample Size": 1093,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "American Indian/Alaska Native, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 6.8,
    "95% CI (%)": "0.0 - 14.8",
    "Sample Size": 32,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24.1,
    "95% CI (%)": "19.8 - 28.4",
    "Sample Size": 2650,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 15,
    "95% CI (%)": "8.1 - 21.9",
    "Sample Size": 532,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 11,
    "95% CI (%)": "6.7 - 15.2",
    "Sample Size": 1059,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Worse than other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 11.6,
    "95% CI (%)": "0.0 - 23.3",
    "Sample Size": 195,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13,
    "95% CI (%)": "7.3 - 18.8",
    "Sample Size": 812,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 12.5,
    "95% CI (%)": "9.5 - 15.4",
    "Sample Size": 2615,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 11.6,
    "95% CI (%)": "9.0 - 14.2",
    "Sample Size": 3393,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 12.9,
    "95% CI (%)": "10.4 - 15.4",
    "Sample Size": 3990,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17.9,
    "95% CI (%)": "12.0 - 23.9",
    "Sample Size": 839,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 39.9,
    "95% CI (%)": "31.7 - 48.1",
    "Sample Size": 918,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 20.1,
    "95% CI (%)": "16.6 - 23.7",
    "Sample Size": 3080,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 2.6,
    "95% CI (%)": "1.2 - 3.9",
    "Sample Size": 1858,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 9,
    "95% CI (%)": "6.5 - 11.5",
    "Sample Size": 2687,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 7.7,
    "95% CI (%)": "5.7 - 9.7",
    "Sample Size": 3587,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 21.6,
    "95% CI (%)": "16.8 - 26.4",
    "Sample Size": 1825,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 16.5,
    "95% CI (%)": "12.5 - 20.4",
    "Sample Size": 1836,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24.2,
    "95% CI (%)": "19.9 - 28.5",
    "Sample Size": 2493,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 1.8,
    "95% CI (%)": "0.1 - 3.4",
    "Sample Size": 1419,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 9.2,
    "95% CI (%)": "6.1 - 12.2",
    "Sample Size": 1614,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 3.7,
    "95% CI (%)": "1.8 - 5.6",
    "Sample Size": 1914,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 12.1,
    "95% CI (%)": "5.4 - 18.8",
    "Sample Size": 551,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.2,
    "95% CI (%)": "10.8 - 15.6",
    "Sample Size": 4348,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17.7,
    "95% CI (%)": "7.8 - 27.6",
    "Sample Size": 416,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is somewhat difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 9,
    "95% CI (%)": "0.2 - 17.8",
    "Sample Size": 159,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is a little difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 10.4,
    "95% CI (%)": "5.5 - 15.4",
    "Sample Size": 334,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 2.7,
    "95% CI (%)": "0.0 - 5.4",
    "Sample Size": 189,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 16,
    "95% CI (%)": "5.3 - 26.7",
    "Sample Size": 164,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 14.1,
    "95% CI (%)": "11.5 - 16.7",
    "Sample Size": 3879,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is very difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 6.3,
    "95% CI (%)": "0.0 - 18.0",
    "Sample Size": 128,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 14.1,
    "95% CI (%)": "11.6 - 16.6",
    "Sample Size": 4251,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 9.9,
    "95% CI (%)": "0.2 - 19.6",
    "Sample Size": 173,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 1.5,
    "95% CI (%)": "0.0 - 4.0",
    "Sample Size": 196,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 3,
    "95% CI (%)": "0.3 - 5.7",
    "Sample Size": 285,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.7,
    "95% CI (%)": "11.3 - 16.2",
    "Sample Size": 4321,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 5.5,
    "95% CI (%)": "0.0 - 13.9",
    "Sample Size": 135,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 4.8,
    "95% CI (%)": "0.0 - 12.2",
    "Sample Size": 176,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.8,
    "95% CI (%)": "11.4 - 16.3",
    "Sample Size": 4293,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.7,
    "95% CI (%)": "11.3 - 16.2",
    "Sample Size": 4328,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.4,
    "95% CI (%)": "11.0 - 15.8",
    "Sample Size": 4353,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 2.9,
    "95% CI (%)": "1.4 - 4.3",
    "Sample Size": 2745,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 14.2,
    "95% CI (%)": "11.6 - 16.7",
    "Sample Size": 4226,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 37.9,
    "95% CI (%)": "31.8 - 43.9",
    "Sample Size": 1779,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 22.6,
    "95% CI (%)": "15.6 - 29.6",
    "Sample Size": 1090,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 54.1,
    "95% CI (%)": "40.5 - 67.7",
    "Sample Size": 459,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 9.1,
    "95% CI (%)": "0.3 - 17.9",
    "Sample Size": 253,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17.8,
    "95% CI (%)": "0.0 - 35.6",
    "Sample Size": 148,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 14.5,
    "95% CI (%)": "8.4 - 20.7",
    "Sample Size": 150,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 14.4,
    "95% CI (%)": "7.0 - 21.8",
    "Sample Size": 424,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 6.6,
    "95% CI (%)": "3.3 - 10.0",
    "Sample Size": 736,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 41,
    "95% CI (%)": "30.6 - 51.4",
    "Sample Size": 676,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 26.8,
    "95% CI (%)": "11.3 - 42.3",
    "Sample Size": 275,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 6.4,
    "95% CI (%)": "3.2 - 9.6",
    "Sample Size": 989,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 9.9,
    "95% CI (%)": "3.7 - 16.1",
    "Sample Size": 350,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.2,
    "95% CI (%)": "10.9 - 15.6",
    "Sample Size": 4538,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.4,
    "95% CI (%)": "8.7 - 18.2",
    "Sample Size": 1033,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 7.3,
    "95% CI (%)": "5.0 - 9.6",
    "Sample Size": 2309,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 33.6,
    "95% CI (%)": "25.8 - 41.3",
    "Sample Size": 1196,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 14,
    "95% CI (%)": "10.6 - 17.4",
    "Sample Size": 2973,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Rural",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 9.5,
    "95% CI (%)": "3.6 - 15.4",
    "Sample Size": 105,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.4,
    "95% CI (%)": "10.0 - 16.8",
    "Sample Size": 1460,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 11.6,
    "95% CI (%)": "8.9 - 14.2",
    "Sample Size": 3832,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Low SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.6,
    "95% CI (%)": "4.0 - 23.2",
    "Sample Size": 88,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17.6,
    "95% CI (%)": "12.1 - 23.2",
    "Sample Size": 421,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 14.9,
    "95% CI (%)": "12.0 - 17.7",
    "Sample Size": 3358,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 8.9,
    "95% CI (%)": "4.9 - 12.9",
    "Sample Size": 990,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Not insured",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 4.9,
    "95% CI (%)": "0.8 - 9.1",
    "Sample Size": 615,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 15.5,
    "95% CI (%)": "12.7 - 18.2",
    "Sample Size": 3796,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 14.2,
    "95% CI (%)": "11.6 - 16.7",
    "Sample Size": 4022,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 12.1,
    "95% CI (%)": "5.4 - 18.8",
    "Sample Size": 551,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Asian, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17.1,
    "95% CI (%)": "5.3 - 28.9",
    "Sample Size": 245,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.1,
    "95% CI (%)": "6.2 - 20.0",
    "Sample Size": 501,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 11.4,
    "95% CI (%)": "5.8 - 17.1",
    "Sample Size": 893,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Language of interview",
    "Group Category": "Spanish",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 7.4,
    "95% CI (%)": "1.7 - 13.0",
    "Sample Size": 492,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 9.2,
    "95% CI (%)": "6.1 - 12.2",
    "Sample Size": 1614,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 16.1,
    "95% CI (%)": "12.1 - 20.1",
    "Sample Size": 1815,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 16.5,
    "95% CI (%)": "12.5 - 20.4",
    "Sample Size": 1836,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 11.2,
    "95% CI (%)": "7.4 - 15.0",
    "Sample Size": 1329,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "American Indian/Alaska Native, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 6.8,
    "95% CI (%)": "0.0 - 14.8",
    "Sample Size": 32,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.8,
    "95% CI (%)": "11.1 - 16.4",
    "Sample Size": 3793,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 15.2,
    "95% CI (%)": "11.6 - 18.7",
    "Sample Size": 2237,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 18.6,
    "95% CI (%)": "9.5 - 27.8",
    "Sample Size": 377,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 4.1,
    "95% CI (%)": "0.0 - 8.1",
    "Sample Size": 321,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 11.2,
    "95% CI (%)": "8.2 - 14.3",
    "Sample Size": 2301,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 19.7,
    "95% CI (%)": "14.1 - 25.3",
    "Sample Size": 1093,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 22.7,
    "95% CI (%)": "1.6 - 43.8",
    "Sample Size": 133,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24.1,
    "95% CI (%)": "19.8 - 28.4",
    "Sample Size": 2650,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13,
    "95% CI (%)": "7.3 - 18.8",
    "Sample Size": 812,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 12.5,
    "95% CI (%)": "9.5 - 15.4",
    "Sample Size": 2615,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Worse than other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 11.6,
    "95% CI (%)": "0.0 - 23.3",
    "Sample Size": 195,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 12.9,
    "95% CI (%)": "10.4 - 15.4",
    "Sample Size": 3990,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 15,
    "95% CI (%)": "8.1 - 21.9",
    "Sample Size": 532,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 11.6,
    "95% CI (%)": "9.0 - 14.2",
    "Sample Size": 3393,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17.9,
    "95% CI (%)": "12.0 - 23.9",
    "Sample Size": 839,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 11,
    "95% CI (%)": "6.7 - 15.2",
    "Sample Size": 1059,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 39.9,
    "95% CI (%)": "31.7 - 48.1",
    "Sample Size": 918,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 2.6,
    "95% CI (%)": "1.2 - 3.9",
    "Sample Size": 1858,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 21.6,
    "95% CI (%)": "16.8 - 26.4",
    "Sample Size": 1825,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 9,
    "95% CI (%)": "6.5 - 11.5",
    "Sample Size": 2687,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 7.7,
    "95% CI (%)": "5.7 - 9.7",
    "Sample Size": 3587,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 20.1,
    "95% CI (%)": "16.6 - 23.7",
    "Sample Size": 3080,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 9.2,
    "95% CI (%)": "6.1 - 12.2",
    "Sample Size": 1614,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24.2,
    "95% CI (%)": "19.9 - 28.5",
    "Sample Size": 2493,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 16.5,
    "95% CI (%)": "12.5 - 20.4",
    "Sample Size": 1836,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 12.1,
    "95% CI (%)": "5.4 - 18.8",
    "Sample Size": 551,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 3.7,
    "95% CI (%)": "1.8 - 5.6",
    "Sample Size": 1914,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 1.8,
    "95% CI (%)": "0.1 - 3.4",
    "Sample Size": 1419,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 2.7,
    "95% CI (%)": "0.0 - 5.4",
    "Sample Size": 189,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 16,
    "95% CI (%)": "5.3 - 26.7",
    "Sample Size": 164,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 14.1,
    "95% CI (%)": "11.5 - 16.7",
    "Sample Size": 3879,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is somewhat difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 9,
    "95% CI (%)": "0.2 - 17.8",
    "Sample Size": 159,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is a little difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 10.4,
    "95% CI (%)": "5.5 - 15.4",
    "Sample Size": 334,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.2,
    "95% CI (%)": "10.8 - 15.6",
    "Sample Size": 4348,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is very difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 6.3,
    "95% CI (%)": "0.0 - 18.0",
    "Sample Size": 128,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17.7,
    "95% CI (%)": "7.8 - 27.6",
    "Sample Size": 416,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 9.9,
    "95% CI (%)": "0.2 - 19.6",
    "Sample Size": 173,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.7,
    "95% CI (%)": "11.3 - 16.2",
    "Sample Size": 4321,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 1.5,
    "95% CI (%)": "0.0 - 4.0",
    "Sample Size": 196,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 3,
    "95% CI (%)": "0.3 - 5.7",
    "Sample Size": 285,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 14.1,
    "95% CI (%)": "11.6 - 16.6",
    "Sample Size": 4251,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.7,
    "95% CI (%)": "11.3 - 16.2",
    "Sample Size": 4328,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.4,
    "95% CI (%)": "11.0 - 15.8",
    "Sample Size": 4353,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 5.5,
    "95% CI (%)": "0.0 - 13.9",
    "Sample Size": 135,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Not sure whether eligible",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 4.8,
    "95% CI (%)": "0.0 - 12.2",
    "Sample Size": 176,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.8,
    "95% CI (%)": "11.4 - 16.3",
    "Sample Size": 4293,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 37.9,
    "95% CI (%)": "31.8 - 43.9",
    "Sample Size": 1779,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 2.9,
    "95% CI (%)": "1.4 - 4.3",
    "Sample Size": 2745,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 14.2,
    "95% CI (%)": "11.6 - 16.7",
    "Sample Size": 4226,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 22.6,
    "95% CI (%)": "15.6 - 29.6",
    "Sample Size": 1090,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 54.1,
    "95% CI (%)": "40.5 - 67.7",
    "Sample Size": 459,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 40.7,
    "95% CI (%)": "0.0 - 90.5",
    "Sample Size": 31,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Texas",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 18.8,
    "95% CI (%)": "0.0 - 44.4",
    "Sample Size": 78,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  }
]
